<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for primary vesicoureteric reflux - Williams, G - 2019 | Cochrane Library</title> <meta content="Interventions for primary vesicoureteric reflux - Williams, G - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001532.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for primary vesicoureteric reflux - Williams, G - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001532.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001532.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for primary vesicoureteric reflux" name="citation_title"/> <meta content="Gabrielle Williams" name="citation_author"/> <meta content="NSW Ministry of Health" name="citation_author_institution"/> <meta content="Elisabeth M Hodson" name="citation_author"/> <meta content="elisabeth.hodson@health.nsw.gov.au" name="citation_author_email"/> <meta content="Jonathan C Craig" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD001532.pub5" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/02/20" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001532.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001532.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001532.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acrylic Resins [therapeutic use]; Anti‐Bacterial Agents [therapeutic use]; Antibiotic Prophylaxis; Collagen [therapeutic use]; Dextrans [therapeutic use]; Dimethylpolysiloxanes [therapeutic use]; Fever [etiology, prevention &amp; control]; Hyaluronic Acid [therapeutic use]; Kidney [abnormalities]; Probiotics [therapeutic use]; Randomized Controlled Trials as Topic; Replantation; Ureter [surgery]; Urinary Tract Infections [complications, *prevention &amp; control]; Vesico‐Ureteral Reflux [complications, *therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001532.pub5&amp;doi=10.1002/14651858.CD001532.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="IYhCEbRn";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001532\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001532\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","pt","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001532.pub5",title:"Interventions for primary vesicoureteric reflux",firstPublishedDate:"Feb 20, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IYhCEbRn&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001532.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001532.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001532.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001532.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001532.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001532.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001532.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001532.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001532.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001532.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6859 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001532.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-sec-0125"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-sec-0058"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-sec-0115"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/appendices#CD001532-sec-0130"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/table_n/CD001532StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/table_n/CD001532StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for primary vesicoureteric reflux</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/information#CD001532-cr-0002">Gabrielle Williams</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/information#CD001532-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Elisabeth M Hodson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001532.pub5/information#CD001532-cr-0004">Jonathan C Craig</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/information/en#CD001532-sec-0141">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 20 February 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001532.pub5">https://doi.org/10.1002/14651858.CD001532.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001532-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001532-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001532-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001532-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001532-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001532-abs-0001" lang="en"> <section id="CD001532-sec-0001"> <h3 class="title" id="CD001532-sec-0001">Background</h3> <p>Vesicoureteric reflux (VUR) results in urine passing retrograde up the ureter. Urinary tract infections (UTI) associated with VUR have been considered a cause of permanent renal parenchymal damage in children with VUR. Management has been directed at preventing UTI by antibiotic prophylaxis and/or surgical correction of VUR. This is an update of a review first published in 2004 and updated in 2007 and 2011. </p> </section> <section id="CD001532-sec-0002"> <h3 class="title" id="CD001532-sec-0002">Objectives</h3> <p>The aim of this review was to evaluate the available evidence for both benefits and harms of the currently available treatment options for primary VUR: operative, non‐operative or no intervention. </p> </section> <section id="CD001532-sec-0003"> <h3 class="title" id="CD001532-sec-0003">Search methods</h3> <p>We searched the Cochrane Kidney and Transplant Specialised Register to 3 May 2018 through contact with the Information Specialist using search terms relevant to this review. Studies contained in the Specialised Register are identified through search strategies specifically designed for CENTRAL, MEDLINE, and EMBASE; handsearching conference proceedings, and searching the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. </p> </section> <section id="CD001532-sec-0004"> <h3 class="title" id="CD001532-sec-0004">Selection criteria</h3> <p>RCTs in any language comparing any treatment of VUR and any combination of therapies.</p> </section> <section id="CD001532-sec-0005"> <h3 class="title" id="CD001532-sec-0005">Data collection and analysis</h3> <p>Two authors independently determined study eligibility, assessed quality and extracted data. Dichotomous outcomes were expressed as risk ratios (RR) with 95% confidence intervals (CI) and continuous data as mean differences (MD) with 95% CI. Data were pooled using the random effects model. </p> </section> <section id="CD001532-sec-0006"> <h3 class="title" id="CD001532-sec-0006">Main results</h3> <p>Thirty four studies involving 4001 children were included. Interventions included; long‐term low‐dose antibiotics, surgical reimplantation of ureters, endoscopic injection treatment, probiotics, cranberry products, circumcision, and oxybutynin. Interventions were used alone and in combinations. The quality of conduct and reporting of these studies was variable, with many studies omitting crucial methodological information used to assess the risk of bias. Only four of the 34 studies were considered at low risk of bias across all fields of study quality. The majority of studies had many areas of uncertainty in the risk of bias fields, reflecting missing detail rather than stated poor design. </p> <p>Low‐dose antibiotic prophylaxis compared to no treatment/placebo may make little or no difference to the risk of repeat symptomatic UTI (9 studies, 1667 children: RR 0.77, 95% CI 0.54 to 1.09; low certainty evidence) and febrile UTI (RR 0.83, 95% CI 0.56 to 1.21; low certainty evidence) at one to two years. At one to three years, antibiotic prophylaxis made little or no difference to the risk of new or progressive renal damage on DMSA scan (8 studies, 1503 children: RR 0.73, 95% CI 0.33 to 1.61; low certainty evidence). Adverse events were reported in four studies with little or no difference between treatment groups (1056 children: RR 0.94, 95% CI 0.81 to 1.08; ), but antibiotics increased the likelihood of bacterial drug resistance threefold (187 UTIs: RR 2.97, 95% CI 1.54 to 5.74; moderate certainty evidence). </p> <p>Seven studies compared long‐term antibiotic prophylaxis alone with surgical reimplantation of ureters plus antibiotics, but only two reported the outcome febrile UTI (429 children). Surgery plus antibiotic treatment may reduce the risk of repeat febrile UTI by 57% (RR 0.43, 95% CI 0.27 to 0.70; moderate certainty evidence). There was little or no difference in the risk of new kidney defects detected using intravenous pyelogram at 4 to 5 years (4 studies, 572 children, RR 1.09, 95% CI 0.79 to 1.49; moderate certainty evidence) </p> <p>Four studies compared endoscopic injection with antibiotics alone and three reported the outcome febrile UTI. This analysis showed little or no difference in the risk of febrile UTI with endoscopic injection compared to antibiotics (RR 0.74, 95% CI 0.31 to 1.78; low certainty evidence). Four studies involving 425 children compared two different materials for endoscopic injection under the ureters (polydimethylsiloxane (Macroplastique) versus dextranomer/hyaluronic acid polymer (Deflux), glutaraldehyde cross‐linked (GAX) collagen (GAX) 35 versus GAX 65 and Deflux versus polyacrylate polyalcohol copolymer (VANTRIS)) but only one study (255 children, low certainty evidence) had the outcome of febrile UTI and it reported no difference between the materials. All four studies reported rates of resolution of VUR, and the two studies comparing Macroplastique with Deflux showed that Macroplastique was probably superior to dextranomer/hyaluronic acid polymer (3 months: RR 0.50, 95% CI 0.33 to 0.78; 12 months: RR 0.54 95% CI 0.35 to 0.83; low certainty evidence) </p> <p>Two studies compared probiotic treatment with antibiotics and showed little or no difference in risk of repeat symptomatic UTI (RR 0.82 95% CI 0.56 to 1.21; low certainty evidence) </p> <p>Single studies compared circumcision with antibiotics, cranberry products with no treatment, oxybutynin with placebo, two different surgical techniques and endoscopic injection with no treatment. </p> </section> <section id="CD001532-sec-0007"> <h3 class="title" id="CD001532-sec-0007">Authors' conclusions</h3> <p>Compared with no treatment, the use of long‐term, low‐dose antibiotics may make little or no difference to the number of repeat symptomatic and febrile UTIs in children with VUR (low certainty evidence). Considerable variation in the study designs and subsequent findings prevented drawing firm conclusions on efficacy of antibiotic treatment. </p> <p>The added benefit of surgical or endoscopic correction of VUR over antibiotic treatment alone remains unclear since few studies comparing the same treatment and with relevant clinical outcomes were available for analysis. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001532-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001532-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001532-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001532-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001532-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD001532-abs-0005">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001532-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001532-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001532-abs-0003" lang="en"> <h3>Interventions for primary vesicoureteric reflux</h3> <p><b>What is the issue?</b> </p> <p>Vesicoureteric reflux (VUR) is the backflow of urine from the bladder up the ureters to the kidney. People with VUR are thought to be more likely to get urinary tract infections (UTIs) involving the kidney tissue, which may cause permanent kidney damage. Current treatment options include surgical reimplantation of the ureters, long‐term antibiotics, endoscopic correction by subureteric injection of a substance (injection into the bladder under the ureter), complementary medicines, or a combination of interventions </p> <p><b>What did we do?</b> </p> <p>A literature search identified all randomised studies comparing different treatment options in children with vesicoureteric reflux. Results along with study design details were extracted and compiled. Studies comparing similar treatments and outcomes had data pooled to obtain an estimate of effect on outcomes such as repeat urinary tract infection with illness, urinary tract infection with fever and kidney damage. </p> <p><b>What did we find?</b> </p> <p>A total of 34 randomised studies, involving 4001 children were identified and underwent data extraction and analysis. The most frequent comparisons were for long‐term, low‐dose antibiotics with no treatment (8 studies) or placebo (4 studies) and antibiotics versus surgical reimplantation of ureters plus antibiotics (7 studies). Other treatments looked at endoscopic correction by injection compared with antibiotics (3 studies), different materials for endoscopic correction (2 studies) circumcision (1 study), probiotics (1 study), cranberry product (1 study), and oxybutynin (2 studies). </p> <p>Meta‐analysis of similar studies found that long‐term low‐dose antibiotic treatment compared with no treatment may lead to little or no difference in the risk for repeat UTIs in children with VUR. Associated side effects were infrequent and minor, but prophylaxis was associated with a threefold increased risk of bacterial resistance to the treatment drug in later infections. Surgery decreased the number of repeat UTIs with fever, but did not change the number of children developing UTI with illness or kidney damage. Many studies did not contribute to the meta‐analysis as they failed to report relevant outcomes or were single studies examining a treatment option not used by other studies or combinations of treatments. </p> <p><b>Conclusions</b> </p> <p>Long‐term low‐dose antibiotic treatment in children with VUR makes little or no difference to the risk of repeat UTI causing a person to be unwell. Surgery may reduce the risk of repeat UTI with fever however this is based on two studies of 429 children who may not represent the majority and may not bear true in a more general group of children with VUR. Complementary therapies such as probiotics and cranberry were trialled in single or two studies and do not provide evidence of sufficient certainty to support or deny their use. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001532-sec-0125" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001532-sec-0125"></div> <h3 class="title" id="CD001532-sec-0126">Implications for practice</h3> <section id="CD001532-sec-0126"> <p>Compared with no treatment, use of long‐term low‐dose antibiotics may make little or no difference to the number of repeat symptomatic and febrile UTIs in children with VUR. Small studies of variable methodological quality and a large amount of unexplained heterogeneity in the analysis makes drawing firm conclusions challenging. Prophylaxis produced few side effects but was associated with a threefold increase in prophylactic drug resistance in subsequent UTIs. </p> <p>The added benefit of surgery over long‐term low‐dose antibiotic use remains uncertain. Although there was a significant reduction in repeat episodes of febrile UTI, there were no differences in either symptomatic UTI or renal damage. Informed decision making should consider the risk of adverse events associated with surgery. Correcting VUR using endoscopic approaches would theoretically reduce these risks. However there were few studies of low methodological quality so endoscopic correction may make little or no difference to number of symptomatic or febrile UTIs or in new or progressive renal damage. </p> </section> <h3 class="title" id="CD001532-sec-0127">Implications for research</h3> <section id="CD001532-sec-0127"> <p>Identifying which children are at risk of repeat UTI is difficult and relying only on VUR status is not helpful. Correction of severe VUR may alleviate problems in some children and as such the role of surgery and endoscopic treatment for the management of VUR needs further exploration. Of specific interest would be the impact of VUR correction by endoscopic subureteric injection without antibiotics versus no treatment on the incidence of febrile UTI and renal parenchymal injury assessed by DMSA scan. The role of prophylactic treatment using complimentary medicines such as cranberry product and probiotics is uncertain and larger, well designed studies may clarify their efficacy. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001532-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001532-sec-0022"></div> <div class="table" id="CD001532-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotic prophylaxis versus surveillance or no treatment for primary vesicoureteric reflux</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Antibiotic prophylaxis versus surveillance or no treatment for primary VUR</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> primary VUR<br/> <b>Setting:</b> paediatric clinics<br/> <b>Intervention:</b> antibiotic prophylaxis<br/> <b>Comparison:</b> surveillance or no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with surveillance or no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Antibiotic prophylaxis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptomatic UTI by 1 to 2 years: antibiotics versus no prophylaxis</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>222 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>171 per 1,000<br/> (120 to 242) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.77<br/> (0.54 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1667 (9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Poor clarity of methods in many studies may lead to bias and this could explain the inconsistent findings across these studies. This reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Febrile UTI by 1 to 2 years: antibiotics versus no prophylaxis</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>143 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>118 per 1,000<br/> (80 to 172) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.83<br/> (0.56 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1667 (9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Poor clarity of methods in many studies may lead to bias and this could explain the inconsistent findings across these studies. This reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptomatic UTI; antibiotics versus placebo in trials with low risk of bias across all domains </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>173 per 1,000<br/> (81 to 364) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.85<br/> (0.40 to 1.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>943 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two relatively large studies showed consistent results but the third small study with small numbers of participants and few events was not consistent </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Resolution of VUR after 1 to 2 years: unit of analysis (children)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>153 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>223 per 1,000<br/> (108 to 456) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.46<br/> (0.71 to 2.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>262 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Poor clarity of methods in some studies and imprecision due to small numbers of included participants may lead to bias. This reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>342 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>321 per 1,000<br/> (277 to 369) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.94<br/> (0.81 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1056 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Design faults in one study reduces our confidence in the evidence</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Microbial resistance to prophylactic drug: unit of analysis (UTI)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>237 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>645 per 1,000<br/> (439 to 949) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.72<br/> (1.85 to 4.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>259 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small sample sizes of participants with UTI makes the results imprecise and reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>UTI:</b> Urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Most studies had serious design faults </p> <p><sup>2</sup> Inconsistency between study results with one study showing results opposite to the other studies </p> <p><sup>3</sup> Small number of events in most studies </p> <p><sup>4</sup> One study had a serious design fault </p> <p><sup>5</sup> Small numbers of urinary tract infections results in imprecision </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001532-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Surgical reimplantation of ureters plus antibiotics versus antibiotics alone for primary vesicoureteric reflux</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Surgical reimplantation of ureters plus antibiotics versus antibiotics alone for primary VUR</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> primary VUR<br/> <b>Setting:</b> paediatric clinics<br/> Intervention: surgical reimplantation of ureters plus antibiotics<br/> <b>Comparison:</b> antibiotics alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotics alone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Surgical reimplantation of ureters plus antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All symptomatic UTI by 4 to 5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>307 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>291 per 1,000<br/> (205 to 414) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.95<br/> (0.67 to 1.35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>297 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only one study evaluated this outcome so our confidence in the evidence is reduced</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Febrile UTI by 5 years: surgical correction + antibiotics versus antibiotics alone</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>220 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>95 per 1,000<br/> (59 to 154) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.43<br/> (0.27 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>429 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies evaluated this outcome but one of these had risk of bias issues so our confidence in the evidence is reduced </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat positive urine cultures by 4 to 5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>369 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>365 per 1,000<br/> (291 to 465) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.99<br/> (0.79 to 1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>479 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Three studies evaluated this outcome but two of these had risk of bias issues reducing our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New renal parenchymal defects (scars and thinning) on IVP: unit of analysis (children) at 4 to 5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>195 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>213 per 1,000<br/> (154 to 291) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.09<br/> (0.79 to 1.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>572 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Four studies evaluated this outcome but three of these had risk of bias issues reducing our confidence in the issues </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ESKD</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>38 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1,000<br/> (9 to 191) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.07<br/> (0.23 to 5.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Few participants included in the analysis and such imprecise findings are of limited clinical use </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertension</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>76 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1,000<br/> (19 to 260) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.93<br/> (0.25 to 3.42) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Few participants included in the analysis and such imprecise findings are of limited clinical use </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Correction of VUR: unit of analysis (children) after 3 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>323 per 1,000<br/> (138 to 763) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.29<br/> (0.55 to 3.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One small study at high risk of bias in all domains evaluated this outcome so our confidence in the evidence is very low </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of UTI with microbial resistance (resistant organisms)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>ESKD:</b> end‐stage kidney disease; <b>IVP:</b> intravenous pyelography; <b>RR:</b> Risk ratio; <b>UTI:</b> Urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Single study with relatively small number of included participants </p> <p><sup>2</sup> One included study was at unclear risk of attrition and selection bias </p> <p><sup>3</sup> Two studies were at unclear risk of selection bias and one had unclear allocation concealment </p> <p><sup>4</sup> Both studies had significant risk of bias issues </p> <p><sup>5</sup> Small studies with few events </p> <p><sup>6</sup> Single study at high risk of bias in all domains </p> <p><sup>7</sup> Very small study with few participants </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001532-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Endoscopic injection treatment versus antibiotics alone for primary vesicoureteric reflux</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Endoscopic injection treatment versus antibiotics alone for primary VUR</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> primary VUR<br/> <b>Setting:</b> paediatric clinics<br/> <b>Intervention:</b> endoscopic injection treatment<br/> <b>Comparison:</b> antibiotics alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotics alone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with endoscopic injection treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All symptomatic UTI by 1 to 2 years: endoscopic correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>225 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1,000<br/> (83 to 393) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.80<br/> (0.37 to 1.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies had risk of bias issues and inconsistency between results limited our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Febrile UTI by 1 to 2 years: endoscopic correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>155 per 1,000<br/> (65 to 373) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.74<br/> (0.31 to 1.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies had risk of bias issues and inconsistency between results limited our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat positive urine culture by 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/> (0 to 0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 7.15<br/> (0.42 to 121.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single small study with no events and risk of bias issues reduces our confidence in the results </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total new and progressive Renal parenchymal abnormalities on DMSA scan at 1 to 2 years: endoscopic correction + antibiotics versus antibiotics alone (unit of analysis: children) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>102 per 1,000<br/> (31 to 336) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.20<br/> (0.36 to 3.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>208 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies had risk of bias issues and there was imprecision in the results reducing our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Resolution of VUR (grade 0) for endoscopic correction + antibiotics versus antibiotics alone (unit of analysis: children) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>156 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>418 per 1,000<br/> (244 to 720) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.69<br/> (1.57 to 4.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies had risk of bias issues and the small numbers of included participants resulted in imprecision reducing our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Microbial resistance to the prophylactic drug</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>800 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>504 per 1,000<br/> (272 to 920) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.63<br/> (0.34 to 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study reported this outcome with a small of urinary tract infections seriously limiting our confidence in this outcome </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>DMSA:</b> 99m‐techetium dimercaptosuccinic acid; <b>RR:</b> Risk ratio; <b>UTI:</b> Urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Significant risk of bias issues in all studies </p> <p><sup>2</sup> Inconsistent results between studies </p> <p><sup>3</sup> Small numbers of participants resulting in imprecision </p> <p><sup>4</sup> Small numbers of events </p> <p><sup>5</sup> Small number of events and small numbers of UTI resulting in imprecision </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001532-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Macroplastique versus dextranomer/hyaluronic acid polymer (Deflux) to correct vesicoureteric reflux</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Macroplastique versus Deflux to correct VUR</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> primary VUR<br/> <b>Setting:</b> paediatric clinics<br/> <b>Intervention:</b> Macroplastique<br/> <b>Comparison:</b> Deflux </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with macroplastique</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Deflux</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of children with febrile UTI</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>74 per 1,000<br/> (30 to 180) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.09<br/> (0.45 to 2.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study with few events and risk of bias issues reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of children with afebrile UTI</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>177 per 1,000<br/> (55 to 573) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.68<br/> (0.52 to 5.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study with few events and risk of bias issues reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of ureters with persistent VUR &gt; grade 1 at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>210 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>113 per 1,000<br/> (73 to 174) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.54<br/> (0.35 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>472 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies with risk of bias issues moderately reduces our confidence in the results</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of kidneys with temporary renal dilatation after injection</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>214 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>396 per 1,000<br/> (219 to 718) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.85<br/> (1.02 to 3.35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study with few events and risk of bias issues reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ureteral obstruction</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 1,000<br/> (3 to 88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.46<br/> (0.25 to 8.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>399 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study with few events and risk of bias issues reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Post operative flank pain</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1,000<br/> (7 to 143) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.45<br/> (0.33 to 6.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study with few events and risk of bias issues reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New renal parenchymal defects on DMSA scan (kidney injury)<br/> Follow up: range 1 years to 3 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>Deflux:</b> dextranomer/hyaluronic acid polymer; <b>DMSA:</b> 99m‐techetium dimercaptosuccinic acid; <b>RR:</b> Risk ratio; <b>UTI:</b> Urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Single study with several risk of bias issues </p> <p><sup>2</sup> Small numbers of events resulting in imprecision </p> <p><sup>3</sup> Two studies with several risk of bias issues </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001532-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Probiotics versus antibiotic prophylaxis for primary vesicoureteric reflux</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Probiotics compared to antibiotic prophylaxis for primary VUR</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> primary VUR<br/> <b>Setting:</b> paediatric clinics<br/> <b>Intervention:</b> probiotics<br/> <b>Comparison:</b> antibiotic prophylaxis </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic prophylaxis</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with probiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All symptomatic UTI by 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>315 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>258 per 1,000<br/> (176 to 381) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.82<br/> (0.56 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>248 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both studies had significant risk of bias issues and also small numbers of included participants limiting our confidence in the results </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Febrile UTI by 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>183 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>150 per 1,000<br/> (68 to 335) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.82<br/> (0.37 to 1.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both studies had significant risk of bias issues and also small numbers of included participants limiting our confidence in the results </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>E. coli resistance to prophylactic drug</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1,000 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>380 per 1,000<br/> (210 to 690) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.38<br/> (0.21 to 0.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The single study had significant risk of bias issues and also small numbers of included participants limiting our confidence in the results </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Renal parenchymal defects on DMSA scan ‐ Patient data at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>364 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>251 per 1,000<br/> (156 to 404) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.69<br/> (0.43 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both studies had significant risk of bias issues and also small numbers of included participants limiting our confidence in the results </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Resolution of VUR</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>UTI:</b> Urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Two small studies with significant design issues </p> <p><sup>2</sup> Small numbers of included participants </p> <p><sup>3</sup> One small study with significant design issues </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001532-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001532-sec-0023"></div> <section id="CD001532-sec-0024"> <h3 class="title" id="CD001532-sec-0024">Description of the condition</h3> <p>Primary vesicoureteric reflux (VUR) is thought to be a maturational abnormality of the vesicoureteric junction, which results in retrograde passing of urine up the ureter during voiding. Although the exact prevalence is unknown, about a third of children investigated after a urinary tract infection (UTI), show evidence of VUR (<a href="./references#CD001532-bbs2-0061" title="SmellieJM , PoultonA , PrescodNP . Retrospective study of children with renal scarring associated with reflux and urinary infection. BMJ1994;308(6938):1193‐6. [MEDLINE: 8180534] ">Smellie 1994</a>). UTI is common, affecting 5% to 10% of all children (<a href="./references#CD001532-bbs2-0050" title="HellstromA , HansonE , HansonnS , HjalmasK , JodalU . Association between urinary symptoms at 7 years old and previous urinary tract infection. Archives of Disease in Childhood1991;66(2):232‐4. [MEDLINE: 2001110] ">Hellstrom 1991</a>), with about 20% of them likely to suffer a recurrence (<a href="./references#CD001532-bbs2-0061" title="SmellieJM , PoultonA , PrescodNP . Retrospective study of children with renal scarring associated with reflux and urinary infection. BMJ1994;308(6938):1193‐6. [MEDLINE: 8180534] ">Smellie 1994</a>, <a href="./references#CD001532-bbs2-0057" title="PanarettoKS , CraigJC , KnightJF , Howman‐GilesR , SureshkumarP , RoyLP . Risk factors for recurrent urinary tract infection in preschool children. Journal of Paediatrics &amp; Child Health1999;35:454‐9. [MEDLINE: 10571758] ">Panaretto 1999</a>). VUR is thought to predispose children to UTI and renal involvement during a UTI can potentially cause permanent renal damage, possibly in up to 15% of patients (<a href="./references#CD001532-bbs2-0055" title="MontiniG , ToffoloA , ZucchettaP , Dall'AmicoR , GobberD , CalderanA , et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non‐inferiority trial. BMJ2007;335(7616):386. [MEDLINE: 17611232] ">Montini 2007b</a>). Retrospective analyses of selected individuals with renal scarring, have reported hypertension and chronic kidney disease (CKD) in approximately 20% and 10% respectively (<a href="./references#CD001532-bbs2-0054" title="MartinellJ , Lidin‐JansonG , JagenburgR , SivertssonR , ClaessonI , JodalU . Girls prone to urinary infections followed into adulthood. Indices of renal disease. Pediatric Nephrology1996;10(2):139‐42. [MEDLINE: 8703696] ">Martinell 1996</a>; <a href="./references#CD001532-bbs2-0062" title="SmellieJM , PrescodNP , ShawPJ , RisdonRA , BryantTN . Childhood reflux and urinary infection: a follow‐up of 10‐41 years in 226 adults. Pediatric Nephrology1998;12(9):727‐36. [MEDLINE: 9874316] ">Smellie 1998</a>). However data from a prospective cohort study indicated that these adverse outcomes occur considerably less frequently (<a href="./references#CD001532-bbs2-0063" title="WennerstromM , HanssonS , JodalU , SixtR , StoklandE . Renal function 16 to 26 years after the first urinary tract infection in childhood. Archives of Pediatrics &amp; Adolescent Medicine2000;154(4):339‐45. [MEDLINE: 10768669] ">Wennerstrom 2000a</a>; <a href="./references#CD001532-bbs2-0064" title="WennerstromM , HanssonS , HednerT , HimmelmannA , JodalU . Ambulatory blood pressure 16‐26 years after the first urinary tract infection in childhood. Journal of Hypertension2000;18(4):485‐91. [MEDLINE: 10779101] ">Wennerstrom 2000b</a>). </p> <p>As a result of the hypothesized causal link between VUR and renal scarring, VUR screening and treatment strategies have largely been directed towards avoidance of UTI and therefore any subsequent renal damage (<a href="./references#CD001532-bbs2-0045" title="BelmanAB . A perspective on vesicoureteral reflux. Urologic Clinics of North America1995;22(1):139‐50. [MEDLINE: 7855950] ">Belman 1995</a>). Preventative treatments have included long‐term, low‐dose antibiotic, surgical correction, endoscopic injection and more recently alternative strategies such as cranberry products and probiotics, Surgical correction of VUR involves techniques such as Politano‐Leadbetter, Lich‐Gregoir and Cohen ureteral reimplantation and the less invasive endoscopic periureteric injection of bulking agents such as polydimethylsiloxane (Macroplastique), dextranomer/hyaluronic acid copolymer (Deflux) or glutaraldehyde cross‐linked bovine collagen (GAX) (<a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>; <a href="./references#CD001532-bbs2-0047" title="FrankenschmidtA , KatzenwadelA , ZimmerhacklLB , SommerkampH . Endoscopic treatment of reflux by subureteric collagen injection: critical review of 5 years' experience. Journal of Endourology1997;11(5):343‐8. [MEDLINE: 9355951] ">Frankenschmidt 1997</a>; <a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>). Although VUR is a common problem in childhood, there has been no consensus regarding the optimal management strategy and practice varies widely. </p> </section> <section id="CD001532-sec-0025"> <h3 class="title" id="CD001532-sec-0025">Description of the intervention</h3> <p>Interventions have included long‐term, low‐dose antibiotic treatment, primarily cotrimoxazole, trimethoprim or nitrofurantoin, for an average of 1.5 years, surgical correction using Poloitano‐Leadbetter, Cohen, Lich‐Gregoir or Glenn Anderson methods, endoscopic injection of various agents, probiotics, cranberry product, circumcision and oxybutynin, </p> </section> <section id="CD001532-sec-0026"> <h3 class="title" id="CD001532-sec-0026">How the intervention might work</h3> <p>Maintaining a constant low‐dose of antibiotic may prevent the overgrowth of pathogenic bacteria that cause a UTI, Surgery to reimplant the ureters should reduce the back flow of urine up the ureters toward the kidney and may reduce the likelihood of infection. Similarly endoscopic injection of an agent to elongate and weld the submucosal tract of the ureter could reduce backward flow of urine toward the kidneys, Cranberry products are thought to contain a substance that reduces the adhesion of bacteria to the bladder wall, reducing the likelihood of overgrowth of bacterial pathogens. Probiotics are thought to increase the number of beneficial bacteria in the body and reduce overgrowth of pathogenic organisms. Circumcision is thought to reduce the carriage of bacteria on the penis and thus reduce the likelihood that bacteria pass up the urethra causing an infection. An anticholinergic agent, such as oxybutynin, is used to treat unstable bladder to reduce symptoms of frequency, incontinence and urgency which may increase the risk of UTI. </p> </section> <section id="CD001532-sec-0027"> <h3 class="title" id="CD001532-sec-0027">Why it is important to do this review</h3> <p>Many treatment options are available for children with VUR to prevent recurring UTI and there is considerable variability in clinical practice worldwide, Identifying and analysing the available data on prophylactic treatment efficacy will guide the clinical care of children with VUR while also identifying evidence gaps for future focus. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001532-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001532-sec-0028"></div> <p>The aim of this review was to evaluate the available evidence for both benefits and harms of the currently available treatment options for primary VUR: operative, non‐operative or no intervention. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001532-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001532-sec-0029"></div> <section id="CD001532-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001532-sec-0031"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) and quasi‐RCTs (RCTs in which allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods) which evaluated any treatment for primary VUR were included. </p> </section> <section id="CD001532-sec-0032"> <h4 class="title">Types of participants</h4> <section id="CD001532-sec-0033"> <h5 class="title">Inclusion criteria</h5> <p>Males and females of any age with primary VUR diagnosed by voiding cystourethrogram (VCUG), with or without UTI. </p> </section> <section id="CD001532-sec-0034"> <h5 class="title">Exclusion criteria</h5> <p>Patients with VUR associated with posterior urethral valves, spina bifida, other urological abnormalities or kidney transplants. </p> </section> </section> <section id="CD001532-sec-0035"> <h4 class="title">Types of interventions</h4> <p>Treatments of VUR including surgery (open and endoscopic techniques), antibiotic prophylaxis of any duration, non‐invasive techniques such as bladder training, complementary medicines, and any combination of therapies. </p> </section> <section id="CD001532-sec-0036"> <h4 class="title">Types of outcome measures</h4> <section id="CD001532-sec-0037"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD001532-list-0001"> <li> <p>Number of patients with symptomatic UTI: defined as symptoms consistent with a UTI which may include local symptoms only e.g. dysuria or systemic symptoms such as fever, together with a positive urine culture. This outcome includes febrile UTI </p> </li> </ul> </p> </section> <section id="CD001532-sec-0038"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD001532-list-0002"> <li> <p>Number of patients with UTI accompanied by fever (temperature &gt; 38°C or &gt; 100.4°F) (a subset of the data from the outcome symptomatic UTI) </p> </li> <li> <p>Number of patients with at least one repeat positive urine culture during follow‐up</p> </li> <li> <p>Renal parenchymal abnormality: defined as new, progression from pre‐existing damage, resolution, end‐stage kidney disease (ESKD) and diagnosed by ultrasound, intravenous pyelography (IVP) or <sup>99m</sup>Tc‐DMSA (dimercaptosuccinic acid) scintigraphy (DMSA scan) </p> </li> <li> <p>Number of previously unaffected subjects who developed hypertension: defined as &gt; 140 mmHg systolic, 90 mmHg diastolic for adults and above the 95th percentiles for systolic and diastolic blood pressures in children </p> </li> <li> <p>Kidney function impairment: defined as a glomerular filtration rate (GFR) (measured either directly or calculated from serum creatinine (eGFR)) &lt; 95th percentile for age, or a decrease in kidney function over the duration of the study </p> </li> <li> <p>Correction or spontaneous resolution of VUR: defined as the number of children and/or ureters without VUR on follow up VCUG </p> </li> <li> <p>Microbial resistance: obstruction following correction of VUR, death or serious injury resulting from the anaesthetic, wound infection, fever, adverse effects of medication including urticaria and gastro‐intestinal reaction. </p> </li> <li> <p>Any reported adverse events (drug or surgery‐related)</p> </li> </ul> </p> </section> </section> </section> <section id="CD001532-sec-0039"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001532-sec-0040"> <h4 class="title">Electronic searches</h4> <p>We searched the <a href="http://kidneyandtransplant.cochrane.org/cochrane-kidney-and-transplant-specialised-register" target="_blank">Cochrane Kidney and Transplant Specialised Register</a> up to 3 May 2018 through contact with the Information Specialist using search terms relevant to this review. The Cochrane Kidney and Transplant Specialised Register contains studies identified from several sources. </p> <p> <ol id="CD001532-list-0003"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Handsearching of kidney‐related journals and the proceedings of major kidney conferences</p> </li> <li> <p>Searching of the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected kidney and transplant journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal &amp; ClinicalTrials.gov.</p> </li> </ol> </p> <p>Studies contained in the Specialised Register are identified through search strategies for CENTRAL, MEDLINE, and EMBASE based on the scope of Cochrane Kidney and Transplant. Details of these strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available in the Specialised Register section of information about <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html" target="_blank">Cochrane Kidney and Transplant</a>. </p> <p>See <a href="./appendices#CD001532-sec-0131">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD001532-sec-0041"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD001532-list-0004"> <li> <p>Reference lists of review articles, relevant studies and clinical practice guidelines.</p> </li> <li> <p>Letters seeking information about unpublished or incomplete studies to investigators known to be involved in previous studies. </p> </li> </ol> </p> </section> </section> <section id="CD001532-sec-0042"> <h3 class="title" id="CD001532-sec-0042">Data collection and analysis</h3> <section id="CD001532-sec-0043"> <h4 class="title">Selection of studies</h4> <p>For the first three versions of this review (<a href="./references#CD001532-bbs2-0065" title="HodsonEM , WheelerDM , SmithGH , CraigJC , VimalachandraD . Interventions for primary vesicoureteric reflux. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD001532.pub3] ">Hodson 2007</a>; <a href="./references#CD001532-bbs2-0066" title="NaglerEV , WilliamsG , HodsonEM , CraigJC . Interventions for primary vesicoureteric reflux. Cochrane Database of Systematic Reviews2011, Issue 6. [DOI: 10.1002/14651858.CD001532.pub4] ">Nagler 2011</a>; <a href="./references#CD001532-bbs2-0069" title="WheelerDM , VimalachandraD , HodsonEM , SmithGH , CraigJC . Interventions for primary vesicoureteric reflux. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD001532.pub2] ">Wheeler 2004</a>) titles and abstracts obtained from the above searches were screened for selection independently by at least two authors. In all cases an overly inclusive selection was preferred to avoid losing relevant studies and to ensure additional studies could be identified from the reference lists. Where suitability was uncertain or no abstract available, the full article was obtained and screened by the same authors. Any disagreements were resolved by discussion with a third author. Authors were contacted to obtain raw or missing data where necessary. For the 2018 update a single author reviewed the titles. </p> </section> <section id="CD001532-sec-0044"> <h4 class="title">Data extraction and management</h4> <p>For the 2004, 2007 and 2011 versions of this review data extraction was conducted independently by at least two authors, using a standardised data extraction form. All studies, reported in a non‐English journal, were translated prior to assessment. Any further information required from the original author was requested by written correspondence and any relevant information obtained in this manner was included in the review. Any disagreements were resolved by discussion with a third author. For the 2018 update, two authors extracted five studies and reviewed agreement; 84 of 90 fields were identical across authors so a single author extracted data from the remaining nine studies. Foreign language articles were translated using <a href="https://translate.google.com.au/" target="_blank">Google Translate</a>. </p> </section> <section id="CD001532-sec-0045"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The following items were independently assessed by two authors using the risk of bias assessment tool (<a href="./references#CD001532-bbs2-0052" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) (<i>see</i><a href="./appendices#CD001532-sec-0132">Appendix 2</a>). In 2018 two authors extracted data from five new studies and compared agreement. A consistent difference between authors was seen and corrected in the remaining studies that were extracted by a single author. Since all three authors are also authors on an included study (<a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>), an independent researcher extracted risk of bias data for that study. </p> <p> <ul id="CD001532-list-0005"> <li> <p>Was there adequate sequence generation?</p> </li> <li> <p>Was allocation adequately concealed?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> </li> <li> <p>Were incomplete outcome data adequately addressed?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting?</p> </li> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> </section> <section id="CD001532-sec-0046"> <h4 class="title">Measures of treatment effect</h4> <section id="CD001532-sec-0047"> <h5 class="title">Dichotomous outcomes</h5> <p>For dichotomous outcomes, the risk ratio (RR) and corresponding 95% confidence interval (CI) were chosen to describe the treatment effects and the precision of their point estimates. Number needed to treat (NNT) estimates were calculated to compare the benefits and harms of each active treatment. </p> </section> <section id="CD001532-sec-0048"> <h5 class="title">Continuous outcomes</h5> <p>Where continuous scales of measurement were used to assess effects of treatment such as blood pressure and kidney function measured by eGFR, the mean difference (MD) and 95% CI was used. Where summary statistics were missing, they were derived from accompanying P values. </p> </section> <section id="CD001532-sec-0049"> <h5 class="title">Planned treatment comparisons</h5> <p> <ul id="CD001532-list-0006"> <li> <p>Antibiotics versus surgery or endoscopic treatment</p> </li> <li> <p>Antibiotics versus placebo or no treatment</p> </li> <li> <p>One antibiotic treatment versus another</p> </li> <li> <p>Surgical or endoscopic correction with no other treatment</p> </li> <li> <p>Any combinations of any active treatment</p> </li> </ul> </p> </section> </section> <section id="CD001532-sec-0050"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis for the primary and most secondary outcomes except resolution of reflux, was children only. For resolution of reflux, we included data for ureters as the unit of analysis and for microbial resistance, rates were expressed per UTI. </p> </section> <section id="CD001532-sec-0051"> <h4 class="title">Dealing with missing data</h4> <p>Email contact was made to authors where there was missing data or methodology details. Responses were infrequent but Professor Jean Smellie provided additional details. </p> </section> <section id="CD001532-sec-0052"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity between studies was analysed using the Cochran's Q statistic with the threshold for statistical significance set at alpha = 0.1 (<a href="./references#CD001532-bbs2-0053" title="LauJ , IoannidisJP , SchmidCH . Quantitative synthesis in systematic reviews. Annals of Internal Medicine1997;127(9):820‐6. [MEDLINE: 9382404] ">Lau 1997</a>). It was also tested by means of the I<sup>2</sup> test, reflecting the percentage of total variation across studies that could be ascribed to heterogeneity (<a href="./references#CD001532-bbs2-0051" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>). Due to an insufficient number of studies within each comparison group, formal evaluation of the different sources of heterogeneity was not possible. </p> </section> <section id="CD001532-sec-0053"> <h4 class="title">Assessment of reporting biases</h4> <p>Publication bias was to be assessed using a funnel plot; there were insufficient studies to do so. </p> </section> <section id="CD001532-sec-0054"> <h4 class="title">Data synthesis</h4> <p>A random effects model was used, with subsequent testing for robustness of the analysis by applying the fixed effect model. </p> </section> <section id="CD001532-sec-0055"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where there is sufficient data univariate analysis was to be used to explore whether the duration of antibiotic treatment, type of antibiotic, type of surgery and material used for endoscopic treatment have an effect on treatment efficacy. Heterogeneity was analysed using the Q statistic with a threshold for the P value of &lt; 0.1 and the I<sup>2</sup> test (<a href="./references#CD001532-bbs2-0051" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>) </p> </section> <section id="CD001532-sec-0056"> <h4 class="title">Sensitivity analysis</h4> <p>To determine the effect of study quality on the primary outcome's pooled summary measure, sensitivity and subgroup analysis was to be performed to examine the influence of design features on results but small numbers of studies and participants prevented this study. </p> <section id="CD001532-sec-0057"> <h5 class="title">'Summary of findings' tables</h5> <p>We presented the main results of the review in 'Summary of findings' tables. These tables present key information concerning the quality of the evidence, the magnitude of the effects of the interventions examined, and the sum of the available data for the main outcomes (<a href="./references#CD001532-bbs2-0058" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011a</a>). The 'Summary of findings' tables also include an overall grading of the evidence related to each of the main outcomes using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach (<a href="./references#CD001532-bbs2-0048" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. [MEDLINE: 18436948] ">GRADE 2008</a>). The GRADE approach defines the quality of a body of evidence as the extent to which one can be confident that an estimate of effect or association is close to the true quantity of specific interest. The quality of a body of evidence involves consideration of within‐trial risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates and risk of publication bias (<a href="./references#CD001532-bbs2-0059" title="SchünemannHJ , OxmanAD , HigginsJP , DeeksJJ , GlasziouP , GuyattGH . Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011b</a>). We presented the following outcomes in the 'Summary of findings' tables. </p> <p> <ul id="CD001532-list-0007"> <li> <p>UTI</p> <ul id="CD001532-list-0008"> <li> <p>Symptomatic UTI</p> </li> <li> <p>Febrile UTI</p> </li> <li> <p>Asymptomatic (repeat positive urine culture; afebrile UTI)</p> </li> </ul> </li> <li> <p>Renal parenchymal abnormality</p> </li> <li> <p>Spontaneous resolution or surgical correction of VUR; persistent VUR</p> </li> <li> <p>Adverse events</p> <ul id="CD001532-list-0009"> <li> <p>ESKD</p> </li> <li> <p>Hypertension</p> </li> <li> <p>Drug related (e.g. vomiting, rash, thrush)</p> </li> <li> <p>Surgery related (e.g. ureteral obstruction, post‐operative pain)</p> </li> </ul> </li> <li> <p>Microbial resistance</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001532-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001532-sec-0058"></div> <section id="CD001532-sec-0059"> <h3 class="title">Description of studies</h3> <section id="CD001532-sec-0060"> <h4 class="title">Results of the search</h4> <p>The first version of this review (<a href="./references#CD001532-bbs2-0069" title="WheelerDM , VimalachandraD , HodsonEM , SmithGH , CraigJC . Interventions for primary vesicoureteric reflux. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD001532.pub2] ">Wheeler 2004</a>) included 10 studies (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>; <a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>; <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>) The International Reflux Study was reported in a European (<a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>) and an American arm (<a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>) and these reports were treated as two separate studies. Two studies were published as abstracts in conference proceedings only (<a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>). </p> <p>The second version of this review (<a href="./references#CD001532-bbs2-0065" title="HodsonEM , WheelerDM , SmithGH , CraigJC , VimalachandraD . Interventions for primary vesicoureteric reflux. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD001532.pub3] ">Hodson 2007</a>), searched literature up to June 2006 and identified one new study (<a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>) along with two additional reports of the European arm of the International Reflux Study (<a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>). </p> <p>A third update of this review (<a href="./references#CD001532-bbs2-0066" title="NaglerEV , WilliamsG , HodsonEM , CraigJC . Interventions for primary vesicoureteric reflux. Cochrane Database of Systematic Reviews2011, Issue 6. [DOI: 10.1002/14651858.CD001532.pub4] ">Nagler 2011</a>) searched the literature up to August 2010 and included an additional nine studies (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>). <a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a> was published only as an abstract and <a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a> was originally published in Czech and was translated before assessment. We also found two papers that belonged to previously included studies (<a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>). One ongoing study was identified (<a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>). </p> <p>The current update searched literature up to May 2018 and adds a further 14 studies (<a href="./references#CD001532-bbs2-0001" title="AhnSH , ChoiHR , ChoSJ , LeeSJ . The effect of oxybutynin on spontaneous resolution of primary vesicoureteral reflux in children [abstract no: FC9‐02]. Nephrology2003;8(Suppl 1):A24. AhnSH , ShimSY , LeeJW , ChoSJ , LeeSJ . The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux. Journal of the Korean Society of Pediatric Nephrology2003;7(2):174‐80. [CENTRAL: CN‐01044096] ">Ahn 2003</a>; <a href="./references#CD001532-bbs2-0006" title="DotisJ , PrintzaN , StabouliS , PavlakiA , SamaraS , PapachristouF . Efficasy of cranberry capsules to prevent recurrences of urinary tract infections [abstract no: P351]. Pediatric Nephrology2014;29(9):1793‐4. [EMBASE: 71662748] ">Dotis 2014</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>; <a href="./references#CD001532-bbs2-0011" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0017" title="KojimaY , MizunoK , UmemotoY , YasuiT , HayashiY , KohriK . Ureteral advancement in patients undergoing laparoscopic extravesical ureteral reimplantation for treatment of vesicoureteral reflux. Journal of Urology2012;188(2):582‐7. [MEDLINE: 22704095] ">Kojima 2012</a>; <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>; <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>). <a href="#CD001532-fig-0001">Figure 1</a> details the study selection process and results. </p> <div class="figure" id="CD001532-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD001532-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD001532-sec-0061"> <h4 class="title">Included studies</h4> <p>Thirty two of 34 studies included two study arms and two studies (<a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>) involved three comparisons. </p> <p><b>Antibiotic prophylaxis versus no treatment/placebo</b> </p> <p>In eight studies (796 children) antibiotic treatment was compared with no treatment (<a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>) and with placebo in four studies involving 984 children (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>). In <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a> no treatment was compared with two antibiotic prophylaxis regimens (daily or intermittent antibiotic administration). Nine of the 12 studies reported the outcome of repeat symptomatic UTI. In eight of the 12 studies, participants were recruited after at least one symptomatic UTI (<a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>), in two studies children had not experienced a UTI but had VUR detected after antenatal ultrasonography (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>), and in two studies, details on prior UTI were not reported (<a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>). Two studies included children with the entire spectrum of VUR grade (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>); two studies included children with grades I to IV (<a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>); seven studies included various lower grades of VUR (<a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>); and one study (<a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>) did not report VUR grade details. Five studies did not report the gender of participating children (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>) while in the remaining seven studies girls (990) outnumbered boys (331), with an extreme imbalance in <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a> (558 girls to 49 boys). In three studies (<a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>), the investigators included both children with and without VUR but for this review we included only the data from children with VUR. Antibiotic treatment duration ranged from one to three years, with the most common practice being one year (5 studies). Two studies did not report antibiotic duration (<a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>) </p> <p>Adherence was addressed in six studies (<a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>, <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>, <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>). </p> <p> <ul id="CD001532-list-0010"> <li> <p><a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a> measured adherence by weighing returned medication bottles and compliance was reported as not different between the two treatment groups </p> </li> <li> <p><a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a> tested the urine samples of children that developed a febrile UTI for presence of the prophylactic drug. He found all patients were adherent. </p> </li> <li> <p><a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a> found 71% of participants were adherent when assessed by measuring antimicrobial activity in a sample of screened urine samples. The reported adherence rate was 86% according to the visual analogue questionnaire. </p> </li> <li> <p><a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> tested adherence by weighing the bottles at each clinic visit as well as by direct questioning of the parents. The authors reported no difference in the frequency of measured non‐adherence between the groups. </p> </li> <li> <p><a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a> report stated that adherence to the antibiotic prophylaxis had been assessed by asking questions during every follow‐up visit, but no findings were provided. </p> </li> <li> <p><a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a> measured adherence by collecting used and unused medication bottles, by direct questioning at clinic visits and patient diaries. 467 children were reported as being 75% compliant with medication while 91 children in the antibiotic group and 76 children in the placebo group stopped taking the medication. No significant difference between adherence rates across the two treatment groups was reported. </p> </li> </ul> </p> <p><b>Surgical reimplantation of the ureters</b> </p> <p>In seven studies (815 children) the effectiveness of low‐dose antibiotic prophylaxis, given for one to five years, was compared with ureteric reimplantation by open surgery, using different surgical methods (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>). Only one study (<a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>) reported the outcome of repeat symptomatic UTI, Five studies recruited children with at least one UTI while <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a> did not report this detail. Three studies involved children with VUR of grades III and IV (<a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>). One study (<a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>) included children with grades III to V VUR, <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a> included children with grades III to IV and <a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a> included children with grades II (with scarring) and III to V. <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a> did not report VUR grades of participating children. <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a> and <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a> did not report gender. A total of 368 girls and 144 boys were included in the remaining studies. </p> <p><a href="./references#CD001532-bbs2-0017" title="KojimaY , MizunoK , UmemotoY , YasuiT , HayashiY , KohriK . Ureteral advancement in patients undergoing laparoscopic extravesical ureteral reimplantation for treatment of vesicoureteral reflux. Journal of Urology2012;188(2):582‐7. [MEDLINE: 22704095] ">Kojima 2012</a> compared two different surgical methods, reimplantation with and without advancement, for the outcomes of positive urine culture and correction of reflux. Children in the study had VUR grades I to V with 13 girls and 17 boys. </p> <p><b>Endoscopic injection treatment</b> </p> <p>Four studies compared endoscopic subureteric injection of Deflux/Dexel (<a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>; <a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>, <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>) with prophylactic antibiotic. Three of these (<a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>) reported the outcome of repeat symptomatic UTI. Four studies (<a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>; <a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>; <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>) compared different injection products, two of which were Deflux with Macroplastique (<a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>; <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>), and these studies reported on symptomatic UTI allowing for pooling of data. One study compared GAX 35 with GAX 65 (<a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>) and one study compared dextranomer/hyaluronic acid polymer with polyacrylate polyalcohol copolymer (Vantris) (<a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>). One study compared endoscopic injection with surgical reimplantation of ureters (<a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>). <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a> included a third arm of no treatment, within their study allowing a comparison between endoscopic injection and no treatment. Two of the four studies comparing endoscopic injection with antibiotics recruited the majority of their participating children after a UTI (<a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>), none of the four studies comparing different endoscopic injection polymers detailed prior UTI history of the participating children and the study of endoscopic injection versus surgical reimplantation also did not report prior UTI history (<a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>). VUR grade was reported by eight of the nine studies, with only <a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a> not reporting this detail. VUR grade ranged widely from all grades to a focus on high grades; III to V. Gender was reported in eight of the nine studies and showed an over representation of girls (445) compared to boys (225). </p> <p><b>Probiotics compared with low dose antibiotic treatment</b> </p> <p>Two studies involving 248 children compared probiotics (<i>Lactobacillus acidophilus</i>) with antibiotic treatment, cotrimoxazole (<a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>) and one study of 85 children compared a combination of two strains of probiotic (<i>Lactobacillus acidophilus</i> and <i>Bifidobacterium lactis</i>) plus antibiotics (nitrofurantoin) with antibiotics alone (<a href="./references#CD001532-bbs2-0020" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>). The three studies reported VUR grade and covered the spectrum of grades from I to V while two of the three studies reported a prior history of UTI (<a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>; <a href="./references#CD001532-bbs2-0020" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>). There were 133 girls and 200 boys who participated. </p> <p><b>Other interventions</b> </p> <p>A study of 76 children (53 girls and 23 boys), with grades I and II VUR and recruited after a previous UTI, compared cranberry capsules with no treatment (<a href="./references#CD001532-bbs2-0006" title="DotisJ , PrintzaN , StabouliS , PavlakiA , SamaraS , PapachristouF . Efficasy of cranberry capsules to prevent recurrences of urinary tract infections [abstract no: P351]. Pediatric Nephrology2014;29(9):1793‐4. [EMBASE: 71662748] ">Dotis 2014</a>). One study of 91 boys with one prior UTI and VUR grades I to III, compared antibiotics alone with antibiotics plus circumcision (<a href="./references#CD001532-bbs2-0011" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>). A study of 149 children, that did not report on grade of VUR, gender or UTI history, compared oxybutynin with placebo for the single outcome VUR resolution (<a href="./references#CD001532-bbs2-0001" title="AhnSH , ChoiHR , ChoSJ , LeeSJ . The effect of oxybutynin on spontaneous resolution of primary vesicoureteral reflux in children [abstract no: FC9‐02]. Nephrology2003;8(Suppl 1):A24. AhnSH , ShimSY , LeeJW , ChoSJ , LeeSJ . The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux. Journal of the Korean Society of Pediatric Nephrology2003;7(2):174‐80. [CENTRAL: CN‐01044096] ">Ahn 2003</a>). </p> </section> <section id="CD001532-sec-0062"> <h4 class="title">Excluded studies</h4> <p>We excluded 10 studies. See <a href="./references#CD001532-sec-0148" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD001532-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>Four studies were considered at low risk of bias for all domains within the risk of bias tool (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>) and all compared low dose antibiotics with placebo. The remaining 30 studies ranged in quality with many study quality fields having a high risk of bias or unclear risk of bias. </p> <p>An overview is provided in <a href="#CD001532-fig-0002">Figure 2</a> and <a href="#CD001532-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD001532-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD001532-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD001532-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD001532-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD001532-sec-0064"> <h4 class="title">Allocation</h4> <section id="CD001532-sec-0065"> <h5 class="title">Sequence generation</h5> <p>The method of sequence generation was at a low risk of bias in 16 studies (<a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>; <a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>; <a href="./references#CD001532-bbs2-0020" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>), at high risk of bias in two studies (<a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>), and unclear risk in 16 studies (<a href="./references#CD001532-bbs2-0001" title="AhnSH , ChoiHR , ChoSJ , LeeSJ . The effect of oxybutynin on spontaneous resolution of primary vesicoureteral reflux in children [abstract no: FC9‐02]. Nephrology2003;8(Suppl 1):A24. AhnSH , ShimSY , LeeJW , ChoSJ , LeeSJ . The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux. Journal of the Korean Society of Pediatric Nephrology2003;7(2):174‐80. [CENTRAL: CN‐01044096] ">Ahn 2003</a>; <a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0006" title="DotisJ , PrintzaN , StabouliS , PavlakiA , SamaraS , PapachristouF . Efficasy of cranberry capsules to prevent recurrences of urinary tract infections [abstract no: P351]. Pediatric Nephrology2014;29(9):1793‐4. [EMBASE: 71662748] ">Dotis 2014</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>; <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0011" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>; <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a>; <a href="./references#CD001532-bbs2-0017" title="KojimaY , MizunoK , UmemotoY , YasuiT , HayashiY , KohriK . Ureteral advancement in patients undergoing laparoscopic extravesical ureteral reimplantation for treatment of vesicoureteral reflux. Journal of Urology2012;188(2):582‐7. [MEDLINE: 22704095] ">Kojima 2012</a>; <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>). </p> </section> <section id="CD001532-sec-0066"> <h5 class="title">Allocation concealment</h5> <p>Allocation concealment was at a low risk of bias in 12 studies (<a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>; <a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>), high risk of bias in three studies (<a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>), and unclear risk in 19 studies (<a href="./references#CD001532-bbs2-0001" title="AhnSH , ChoiHR , ChoSJ , LeeSJ . The effect of oxybutynin on spontaneous resolution of primary vesicoureteral reflux in children [abstract no: FC9‐02]. Nephrology2003;8(Suppl 1):A24. AhnSH , ShimSY , LeeJW , ChoSJ , LeeSJ . The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux. Journal of the Korean Society of Pediatric Nephrology2003;7(2):174‐80. [CENTRAL: CN‐01044096] ">Ahn 2003</a>; <a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0006" title="DotisJ , PrintzaN , StabouliS , PavlakiA , SamaraS , PapachristouF . Efficasy of cranberry capsules to prevent recurrences of urinary tract infections [abstract no: P351]. Pediatric Nephrology2014;29(9):1793‐4. [EMBASE: 71662748] ">Dotis 2014</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>; <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0011" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>; <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a>; <a href="./references#CD001532-bbs2-0017" title="KojimaY , MizunoK , UmemotoY , YasuiT , HayashiY , KohriK . Ureteral advancement in patients undergoing laparoscopic extravesical ureteral reimplantation for treatment of vesicoureteral reflux. Journal of Urology2012;188(2):582‐7. [MEDLINE: 22704095] ">Kojima 2012</a>; <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>; <a href="./references#CD001532-bbs2-0020" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>). </p> </section> </section> <section id="CD001532-sec-0067"> <h4 class="title">Blinding</h4> <p>While it is understood blinding clinicians and participants/carers to a surgical procedure is not easily feasible, blinding of outcome assessment is feasible. </p> <section id="CD001532-sec-0068"> <h5 class="title">Performance bias</h5> <p>Risk of performance bias was low in five studies (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>), high in 16 studies (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>; <a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>), and unclear in 13 studies (<a href="./references#CD001532-bbs2-0001" title="AhnSH , ChoiHR , ChoSJ , LeeSJ . The effect of oxybutynin on spontaneous resolution of primary vesicoureteral reflux in children [abstract no: FC9‐02]. Nephrology2003;8(Suppl 1):A24. AhnSH , ShimSY , LeeJW , ChoSJ , LeeSJ . The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux. Journal of the Korean Society of Pediatric Nephrology2003;7(2):174‐80. [CENTRAL: CN‐01044096] ">Ahn 2003</a>; <a href="./references#CD001532-bbs2-0006" title="DotisJ , PrintzaN , StabouliS , PavlakiA , SamaraS , PapachristouF . Efficasy of cranberry capsules to prevent recurrences of urinary tract infections [abstract no: P351]. Pediatric Nephrology2014;29(9):1793‐4. [EMBASE: 71662748] ">Dotis 2014</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>; <a href="./references#CD001532-bbs2-0011" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>; <a href="./references#CD001532-bbs2-0017" title="KojimaY , MizunoK , UmemotoY , YasuiT , HayashiY , KohriK . Ureteral advancement in patients undergoing laparoscopic extravesical ureteral reimplantation for treatment of vesicoureteral reflux. Journal of Urology2012;188(2):582‐7. [MEDLINE: 22704095] ">Kojima 2012</a>; <a href="./references#CD001532-bbs2-0020" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>; <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>). </p> </section> <section id="CD001532-sec-0069"> <h5 class="title">Detection bias</h5> <p>Risk of detection bias was low in 12 studies (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>); high in four studies (<a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>; <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>), and unclear in 18 studies (<a href="./references#CD001532-bbs2-0001" title="AhnSH , ChoiHR , ChoSJ , LeeSJ . The effect of oxybutynin on spontaneous resolution of primary vesicoureteral reflux in children [abstract no: FC9‐02]. Nephrology2003;8(Suppl 1):A24. AhnSH , ShimSY , LeeJW , ChoSJ , LeeSJ . The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux. Journal of the Korean Society of Pediatric Nephrology2003;7(2):174‐80. [CENTRAL: CN‐01044096] ">Ahn 2003</a>; <a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0006" title="DotisJ , PrintzaN , StabouliS , PavlakiA , SamaraS , PapachristouF . Efficasy of cranberry capsules to prevent recurrences of urinary tract infections [abstract no: P351]. Pediatric Nephrology2014;29(9):1793‐4. [EMBASE: 71662748] ">Dotis 2014</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>; <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0011" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>; <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a>; <a href="./references#CD001532-bbs2-0017" title="KojimaY , MizunoK , UmemotoY , YasuiT , HayashiY , KohriK . Ureteral advancement in patients undergoing laparoscopic extravesical ureteral reimplantation for treatment of vesicoureteral reflux. Journal of Urology2012;188(2):582‐7. [MEDLINE: 22704095] ">Kojima 2012</a>; <a href="./references#CD001532-bbs2-0020" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>; <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>). </p> </section> </section> <section id="CD001532-sec-0070"> <h4 class="title">Incomplete outcome data</h4> <p>Fourteen studies accounted for all study participants in the analysis and report, giving them a low risk of bias (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>; <a href="./references#CD001532-bbs2-0020" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>), 11 studies were classified as high risk of bias (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>; <a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>; <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>; <a href="./references#CD001532-bbs2-0017" title="KojimaY , MizunoK , UmemotoY , YasuiT , HayashiY , KohriK . Ureteral advancement in patients undergoing laparoscopic extravesical ureteral reimplantation for treatment of vesicoureteral reflux. Journal of Urology2012;188(2):582‐7. [MEDLINE: 22704095] ">Kojima 2012</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>). In nine studies it was unclear how many participants were included in the analyses (<a href="./references#CD001532-bbs2-0001" title="AhnSH , ChoiHR , ChoSJ , LeeSJ . The effect of oxybutynin on spontaneous resolution of primary vesicoureteral reflux in children [abstract no: FC9‐02]. Nephrology2003;8(Suppl 1):A24. AhnSH , ShimSY , LeeJW , ChoSJ , LeeSJ . The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux. Journal of the Korean Society of Pediatric Nephrology2003;7(2):174‐80. [CENTRAL: CN‐01044096] ">Ahn 2003</a>; <a href="./references#CD001532-bbs2-0006" title="DotisJ , PrintzaN , StabouliS , PavlakiA , SamaraS , PapachristouF . Efficasy of cranberry capsules to prevent recurrences of urinary tract infections [abstract no: P351]. Pediatric Nephrology2014;29(9):1793‐4. [EMBASE: 71662748] ">Dotis 2014</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>; <a href="./references#CD001532-bbs2-0011" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>), usually because denominators were not reported. </p> </section> <section id="CD001532-sec-0071"> <h4 class="title">Selective reporting</h4> <p>Twelve studies reported the most clinically appropriate outcomes and were considered at low risk of bias (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>; <a href="./references#CD001532-bbs2-0020" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>), Thirteen studies reported only surrogate or not the most clinically relevant outcomes such as resolution of VUR and positive urine culture, and were considered at high risk of bias (<a href="./references#CD001532-bbs2-0001" title="AhnSH , ChoiHR , ChoSJ , LeeSJ . The effect of oxybutynin on spontaneous resolution of primary vesicoureteral reflux in children [abstract no: FC9‐02]. Nephrology2003;8(Suppl 1):A24. AhnSH , ShimSY , LeeJW , ChoSJ , LeeSJ . The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux. Journal of the Korean Society of Pediatric Nephrology2003;7(2):174‐80. [CENTRAL: CN‐01044096] ">Ahn 2003</a>; <a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0006" title="DotisJ , PrintzaN , StabouliS , PavlakiA , SamaraS , PapachristouF . Efficasy of cranberry capsules to prevent recurrences of urinary tract infections [abstract no: P351]. Pediatric Nephrology2014;29(9):1793‐4. [EMBASE: 71662748] ">Dotis 2014</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>; <a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>; <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0011" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>; <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>). In nine studies details on outcomes were ambiguous or poorly detailed meaning there was an unclear risk of reporting bias (<a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>; <a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0017" title="KojimaY , MizunoK , UmemotoY , YasuiT , HayashiY , KohriK . Ureteral advancement in patients undergoing laparoscopic extravesical ureteral reimplantation for treatment of vesicoureteral reflux. Journal of Urology2012;188(2):582‐7. [MEDLINE: 22704095] ">Kojima 2012</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>). </p> </section> <section id="CD001532-sec-0072"> <h4 class="title">Other potential sources of bias</h4> <p>For many studies it was difficult to discern who the children were and how many were reviewed for possible inclusion in the study protocol, thereby largely limiting the ability to evaluate the extent of selection bias. Seven studies were considered at low risk of bias from other sources because patients and methods were well detailed and comprehensive (<a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>; <a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>). Four studies were considered at high risk of bias from other sources, primarily from poorly reported details on how participants were selected (<a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a>; <a href="./references#CD001532-bbs2-0020" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>), while in 23 studies it was difficult to determine other potential biases (<a href="./references#CD001532-bbs2-0001" title="AhnSH , ChoiHR , ChoSJ , LeeSJ . The effect of oxybutynin on spontaneous resolution of primary vesicoureteral reflux in children [abstract no: FC9‐02]. Nephrology2003;8(Suppl 1):A24. AhnSH , ShimSY , LeeJW , ChoSJ , LeeSJ . The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux. Journal of the Korean Society of Pediatric Nephrology2003;7(2):174‐80. [CENTRAL: CN‐01044096] ">Ahn 2003</a>; <a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0006" title="DotisJ , PrintzaN , StabouliS , PavlakiA , SamaraS , PapachristouF . Efficasy of cranberry capsules to prevent recurrences of urinary tract infections [abstract no: P351]. Pediatric Nephrology2014;29(9):1793‐4. [EMBASE: 71662748] ">Dotis 2014</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>; <a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>; <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0011" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0017" title="KojimaY , MizunoK , UmemotoY , YasuiT , HayashiY , KohriK . Ureteral advancement in patients undergoing laparoscopic extravesical ureteral reimplantation for treatment of vesicoureteral reflux. Journal of Urology2012;188(2):582‐7. [MEDLINE: 22704095] ">Kojima 2012</a>; <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>; <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>; <a href="./references#CD001532-bbs2-0034" title="TakvaniA , GokaniC , MalaviyaP . Vesicoureteral reflux ‐ a prospective study of 11 years [abstract]. European Urology Supplements2015;14(2):e505‐e505a. [EMBASE: 71831431] ">Takvani 2015</a>). </p> </section> </section> <section id="CD001532-sec-0073"> <h3 class="title" id="CD001532-sec-0073">Effects of interventions</h3> <p>See: <a href="./full#CD001532-tbl-0001"><b>Summary of findings for the main comparison</b> Antibiotic prophylaxis versus surveillance or no treatment for primary vesicoureteric reflux</a>; <a href="./full#CD001532-tbl-0002"><b>Summary of findings 2</b> Surgical reimplantation of ureters plus antibiotics versus antibiotics alone for primary vesicoureteric reflux</a>; <a href="./full#CD001532-tbl-0003"><b>Summary of findings 3</b> Endoscopic injection treatment versus antibiotics alone for primary vesicoureteric reflux</a>; <a href="./full#CD001532-tbl-0004"><b>Summary of findings 4</b> Macroplastique versus dextranomer/hyaluronic acid polymer (Deflux) to correct vesicoureteric reflux</a>; <a href="./full#CD001532-tbl-0005"><b>Summary of findings 5</b> Probiotics versus antibiotic prophylaxis for primary vesicoureteric reflux</a> </p> <section id="CD001532-sec-0074"> <h4 class="title">Antibiotic prophylaxis versus surveillance or no treatment</h4> <p>The data were analysed using a random and a fixed effects model, without there being an appreciable difference between the summary estimates. Results are presented using the random effects model. See <a href="./full#CD001532-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD001532-sec-0075"> <h5 class="title">Urinary tract infection</h5> <section id="CD001532-sec-0076"> <h6 class="title">Symptomatic and febrile UTI</h6> <p>Of the 12 studies that compared antibiotic prophylaxis with placebo or no treatment, nine reported repeat symptomatic UTI as an outcome and allowed distinction of febrile UTI as a separate entity. One and two year incidence of symptomatic UTI varied from 11% to 36% in the group treated with antibiotics and 7% to 58% in the placebo/no treatment groups. The point estimate for overall effect suggested antibiotic prophylaxis may slightly reduce the risk of repeat symptomatic UTI but the wide confidence interval, includes the point of no difference between the treatment groups indicating that antibiotic prophylaxis compared with placebo/no treatment may make little or no difference to the risk of repeat symptomatic UTI (<a href="./references#CD001532-fig-0004" title="">Analysis 1.1</a>.1 (9 studies, 1667 children): RR 0.77, 95% CI 0.54 to 1.09; I<sup>2</sup> = 59%; low certainty evidence). Individual studies varied widely in results creating large inconsistencies and study designs were often suboptimal leading to a conclusion of low quality evidence and considerable uncertainty in findings. Similarly for the outcome of febrile UTI by one to two years of follow‐up, antibiotic prophylaxis compared with placebo/no treatment may make little or no difference to the outcome of febrile UTI (<a href="./references#CD001532-fig-0004" title="">Analysis 1.1</a>.2 (9 studies, 1667 children): RR 0.83, 95% CI 0.56 to 1.21I<sup>2</sup> = 51%; low certainty evidence). The individual studies were inconsistent and contained considerable bias leading to the assessment of low certainty evidence. </p> <p>Two studies (<a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>) reported outcome data within study arms and separate for girls and boys (<a href="./references#CD001532-fig-0017" title="">Analysis 1.14</a>) and point estimates suggested that in boys, risk of recurrence of febrile UTI was similar whether on antibiotics or with no treatment (RR 1.26, 95% CI 0.53 to 2.99; I<sup>2</sup> = 0%). In girls the point estimate suggested a lower risk for recurrence for those on antibiotic treatment than with no treatment (RR 0.63, 95% CI 0.17 to 2.33; I<sup>2</sup> = 86%). However both estimates included the point of no difference because sample size was small and events not very common, leading to a lack of precision. </p> <p>For these outcomes, there was a large amount of unexplained heterogeneity among studies. We could not identify systematic differences in allocation mechanism, blinding or participant characteristics that explained the heterogeneity. Three studies were rated as low risk of bias across all quality assessment fields (<a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>) and while two studies were reasonably similar in their point estimates (<a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>: RR 0.66 95% CI 0.35 to 1.24; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>: RR 0.55 95% CI 0.38 to 0.78), <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a> was very different (RR 3.26, 95% CI 0.96 to 11.10). Therefore we concluded that in this subgroup of studies, antibiotic prophylaxis compared with placebo probably leads to little or no difference in the risk of repeat UTI (moderate certainty evidence). An explanation might be that of a chance affect in a small sample size; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a> included only 93 children while <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a> and <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> included 607 and 243 children with VUR, respectively. (<a href="./references#CD001532-fig-0004" title="">Analysis 1.1</a>.3). </p> </section> <section id="CD001532-sec-0077"> <h6 class="title">Repeat positive urine culture</h6> <p>In seven studies involving 729 children, the outcome of repeat positive urine culture was reported for urine samples taken in asymptomatic subjects (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>, <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>). The analysis showed a slightly reduced risk of repeat positive urine culture in children taking antibiotics compared to those on placebo/no treatment (<a href="./references#CD001532-fig-0004" title="">Analysis 1.1</a>.4 (7 studies, 729 participants) RR 0.80, 95% CI 0.63 to 1.02; I<sup>2</sup> = 0%). However the confidence interval include the point of no difference so that antibiotic prophylaxis compared with no antibiotics may be little or no difference to the outcome of positive urine culture (low certainty evidence). In addition to comparing a daily antibiotic regimen with surveillance, <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a> introduced an extra treatment arm to compare intermittent treatment three times/week, with no treatment. In the group treated with intermittent antibiotics 2/14 participants (14%) had a repeat positive urine culture and in the no‐treatment group 5/16 patients experienced a repeat positive urine culture (31%) (<a href="./references#CD001532-fig-0004" title="">Analysis 1.1</a>.5 (1 study, 30 children): RR 0.46, 95% CI 0.10 to 2.00). </p> </section> </section> <section id="CD001532-sec-0078"> <h5 class="title">Renal parenchymal abnormality</h5> <p>In eight studies, the acquisition of new renal abnormalities was evaluated by comparing DMSA scans, taken both at study commencement and completion of follow‐up (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>, <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>). Three studies had no events in either group and hence did not contribute data to the analyses (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0007" title="Espino HernandezM , ArcosGB , Melgosa HijosaM , Orive OlondrizB , PenaA , Rodriguez Do FornoA , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] EspinoM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648. ">Espino Hernandez 2012</a>; <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>). Overall antibiotic prophylaxis compared with placebo/no treatment may make little or no difference to the risk of new renal abnormalities (<a href="./references#CD001532-fig-0007" title="">Analysis 1.4</a>.1 (8 studies, 1503 children): RR 0.73, 95% CI 0.33 to 1.61; I<sup>2</sup> = 24%), the risk of deterioration of existing renal abnormalities (<a href="./references#CD001532-fig-0007" title="">Analysis 1.4</a>.2 (3 studies, 446 children): RR 0.68, 95% CI 0.27 to 1.73; I<sup>2</sup> = 0%), or total renal abnormalities (<a href="./references#CD001532-fig-0007" title="">Analysis 1.4</a>.3 (7 studies, 1288 participants): RR 0.83, 95% CI 0.42 to 1.62; I<sup>2</sup> = 42%; low certainty evidence). </p> <p>The study comparing intermittent with continuous prophylaxis (<a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>) showed a very imprecise estimate of the risk of renal parenchymal injury between the two treatments with the effect ranging from a possible 98% reduction to over 8‐fold greater risk (<a href="./references#CD001532-fig-0007" title="">Analysis 1.4</a>.5 (1 study, 30 children): RR 0.38, 95% CI 0.02 to 8.59). </p> </section> <section id="CD001532-sec-0079"> <h5 class="title">Resolution of VUR</h5> <p>Three studies (<a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0028" title="ReddyPP , EvansMT , HughesPA , DangmanB , CooperJ , LepowML , et al. Antimicrobial prophylaxis in children with vesico‐ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance [abstract]. Pediatrics1997;100(3):555‐6. [CENTRAL: CN‐00427967] ">Reddy 1997</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>) reported the VUR status after a two year follow‐up. Overall there was little or no difference in the number of children with persisting VUR (<a href="./references#CD001532-fig-0008" title="">Analysis 1.5</a> (3 studies, 262 children): RR 1.46, 95% CI 0.71 to 2.99; I<sup>2</sup> = 0%; low certainty evidence). </p> </section> <section id="CD001532-sec-0080"> <h5 class="title">Adverse events</h5> <p>Five studies reported adverse effects and the findings were very different for each study (<a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>, <a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>, <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>) (<a href="./references#CD001532-fig-0009" title="">Analysis 1.6</a>). Antibiotic prophylaxis compared with placebo/no treatment may make little or no difference to the number of adverse effects reported (<a href="./references#CD001532-fig-0009" title="">Analysis 1.6</a> (4 studies, 1056 children): RR 0.94, 95% CI 0.81 to 1.08; I<sup>2</sup> = 0%; moderate certainty evidence). </p> <p> <ul id="CD001532-list-0011"> <li> <p><a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a> explicitly stated 'no reported side effects associated with the use of urinary antibiotic prophylaxis'. </p> </li> <li> <p><a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a> reported 12 and 11 adverse events in the antibiotic and placebo groups respectively </p> </li> <li> <p><a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> reported two participants developed thrush while on antibiotics and five developed a rash while on placebo. </p> </li> <li> <p><a href="./references#CD001532-bbs2-0021" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a> reported 25 minor adverse events (out of 211 participants), mainly vomiting or gastro‐intestinal intolerance. These data however included patients without VUR and were not reported per treatment group. </p> </li> <li> <p><a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a> reported similar frequencies of adverse events across the treatment groups with 153 children in the antibiotic and 165 children in the placebo groups experiencing one or more events. </p> </li> </ul> </p> </section> <section id="CD001532-sec-0081"> <h5 class="title">Microbial resistance</h5> <p>Six studies described bacterial resistance to the prophylactic drug in subsequent symptomatic UTIs (<a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>, <a href="./references#CD001532-bbs2-0026" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravanL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from controlled study [abstract no: COD.OC2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>, <a href="./references#CD001532-bbs2-0030" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204 (FC)]. Pediatric Nephrology2007;22(9):1450. Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>). Overall the estimated risk of prophylactic drug resistance in a repeat symptomatic UTI was almost three times higher for children who received antibiotics compared to those on placebo or no treatment (<a href="./references#CD001532-fig-0010" title="">Analysis 1.7</a>.1 (6 studies, 259 urine cultures): RR 2.72, 95% CI 1.85 to 4.00; I<sup>2</sup> = 24%; moderate certainty evidence). Assessment of these studies showed there were some reported design features and led to the conclusion that antibiotic prophylaxis compared with placebo/no treatment probably increases the risk of drug resistance. In <a href="./references#CD001532-bbs2-0010" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarraF , Garicia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>, all of the seven pyelonephritis cases in children given antibiotics were caused by a resistant micro‐organism but authors did not report whether the single case of pyelonephritis in the placebo group was caused by a bacteria that was sensitive or resistant to commonly used antibiotics. </p> </section> <section id="CD001532-sec-0082"> <h5 class="title">Other outcomes</h5> <p>One small study (46 children), only published in abstract form, reported on DTPA measured GFR, and renal growth at the end of a three year follow‐up period (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>). Results were only reported as means, but standard deviations could be derived from the accompanying P value. At thee year follow‐up there was little or no difference in GFR (<a href="./references#CD001532-fig-0011" title="">Analysis 1.8</a> (1 study, 41 children): MD ‐11.00 mL/min/1.73 m<sup>2</sup>, 95% CI ‐31.53 to 9.53) or in renal growth (<a href="./references#CD001532-fig-0012" title="">Analysis 1.9</a> (1 study, 41 children): MD 0.04 cm, 95% CI ‐0.04 to 0.12). </p> <p>The outcomes of ESKD and hypertension were not reported.</p> </section> </section> <section id="CD001532-sec-0083"> <h4 class="title">Surgical reimplantation of ureters plus antibiotics versus antibiotics alone</h4> <p>There was no appreciable difference between the summary estimates using random and fixed effects models. There were insufficient studies to explore potential effect modification using subgroup analysis or meta‐regression. See <a href="./full#CD001532-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD001532-sec-0084"> <h5 class="title">Urinary tract infection</h5> <section id="CD001532-sec-0085"> <h6 class="title">Symptomatic and febrile UTI</h6> <p>Symptomatic UTI was reported in only one surgical study with the finding of little or no difference in risk between the two treatment groups, at four to five (moderate certainty evidence), and five to 10 years. Febrile UTI was reported in both arms of the international reflux study (<a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>, <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>); at five years the risk of repeat febrile UTI was 57% lower in the surgical group (<a href="./references#CD001532-fig-0018" title="">Analysis 2.1</a>.4 (2 studies, 429 participants): RR 0.43 95% CI 0.27 to 0.70; I<sup>2</sup> = 0%). The consistency in these two studies and precision of the estimates suggested surgical correction with antibiotic prophylaxis compared with antibiotic prophylaxis probably reduces the risk of febrile UTI (moderate certainty evidence). Only the European arm reported febrile UTI at five to 10 years and after 10 years. </p> </section> <section id="CD001532-sec-0086"> <h6 class="title">Repeat positive urine culture</h6> <p>Repeat positive urine culture was reported in three studies (<a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>) and the risk estimate showed little or no difference between the treatment groups. (<a href="./references#CD001532-fig-0018" title="">Analysis 2.1</a>.7 (3 studies, 479 participants): RR 0.99 95% CI 0.79 to 1.26; I<sup>2</sup> = 0%; moderate certainty evidence). </p> </section> </section> <section id="CD001532-sec-0087"> <h5 class="title">Renal parenchymal abnormality</h5> <p>Renal parenchymal abnormalities were reported in five studies (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0014" title="HollandNH , KazeeM , DuffD , McRobertsJW . Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux. Reviews of Infectious Diseases1982;4(2):467‐74. [MEDLINE: 6981165] ">Holland 1982</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>) at varying time points. The frequency of renal parenchymal abnormality (scars and renal parenchymal thinning) on IVP at study entry was 56% to 100% with little or no difference between children receiving antibiotic prophylaxis alone and those treated with surgery plus antibiotics. Surgical correction + antibiotic prophylaxis compared with antibiotic prophylaxis probably makes little or no difference to the number of children developing a new renal parenchymal abnormality, either at two years (<a href="./references#CD001532-fig-0019" title="">Analysis 2.2</a>.1 (2 studies, 171 children): RR 1.06, 95% CI 0.33 to 3.42) or at four to five years (<a href="./references#CD001532-fig-0019" title="">Analysis 2.2</a>.2 (4 studies, 572 children): RR 1.09, 95% CI 0.79 to 1.49; moderate certainty evidence). The risk of progression of an existing abnormality was also similar both at two years (<a href="./references#CD001532-fig-0019" title="">Analysis 2.2</a>.3 (1 study, 10 children): RR 7.00, 95% CI 0.45 to 108.26) and at four to five years (<a href="./references#CD001532-fig-0019" title="">Analysis 2.2</a>.4 (3 studies, 468 children): RR 0.99, 95% CI 0.69 to 1.42). When the development of a new or a progressive abnormality were considered as a single outcome at four to five years, there was little or no difference between the two groups (<a href="./references#CD001532-fig-0019" title="">Analysis 2.2</a>.6 (3 studies, 468 children): RR 1.05, 95% CI 0.85 to 1.29). </p> <p>The European (<a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>) and US arms (<a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>) of the International Reflux Study differentiated renal scarring and renal parenchymal thinning on IVP. Surgical correction + antibiotic prophylaxis with antibiotic prophylaxis probably makes little or no difference to the number of patients with renal scars on IVP at zero to five years (<a href="./references#CD001532-fig-0020" title="">Analysis 2.3</a>.1 (2 studies, 418 children): RR 1.28, 95% CI 0.84 to 1.94), at five to 10 years (<a href="./references#CD001532-fig-0020" title="">Analysis 2.3</a>.2 (1 study, 223 children): RR 1.03, 95% CI 0.07 to 16.22) or zero to 10 years in children followed for 10 years in the European arm of the International Reflux Study (<a href="./references#CD001532-fig-0020" title="">Analysis 2.3</a>.3 (1 study, 223 children): RR 1.03, 95% CI 0.53 to 2.00). All risk estimates were fairly imprecise with large confidence intervals that included the point of no affect. In the <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>, renal scarring on IVP was present at entry in 49% of the 306 children originally treated and in 51% of 223 children studied by IVP at 10 years. During the first five years of follow‐up, 40 children (surgery plus antibiotic group (21); antibiotic group (19)) developed new scars. Of these, 28 were among the 223 followed radiologically at 10 years. Only two more children, one from each therapy group, developed new scars between five and 10 years.<br/> <br/> When the data were examined according to the total number of kidneys, at two years of follow‐up, Surgical correction + antibiotic prophylaxis with antibiotic prophylaxis probably makes little or no difference to the number of new abnormalities at 2 years (<a href="./references#CD001532-fig-0023" title="">Analysis 2.6</a>.1 (2 studies, 235 children): RR 1.03, 95% CI 0.31 to 3.37), progressive abnormalities (<a href="./references#CD001532-fig-0023" title="">Analysis 2.6</a>.2 (2 studies, 235 children): RR 1.56, 95% CI 0.24 to 10.08) or total renal parenchymal abnormalities (<a href="./references#CD001532-fig-0023" title="">Analysis 2.6</a>.3 (2 studies, 235 children): RR 1.54, 95% CI 0.24 to 9.95) or at 5 years for new abnormalities (<a href="./references#CD001532-fig-0023" title="">Analysis 2.6</a>.4 (2 studies, 319 children): RR 0.85, 95% CI 0.24 to 3.09), progression in abnormality (<a href="./references#CD001532-fig-0023" title="">Analysis 2.6</a>.5 (2 studies, 319 children): RR 0.84, 95% CI 0.50 to 1.41) or total abnormality (<a href="./references#CD001532-fig-0023" title="">Analysis 2.6</a>.6 (2 studies, 319 children): RR 0.84, 95% CI 0.53 to 1.34). All confidence intervals were wide showing imprecision in the estimate and included the point of no effect. </p> <p>One study evaluated renal parenchymal abnormality with DMSA scan (<a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>); 97% of children had a scintigraphy performed at five years and 73% of children at 10 years. Parenchymal abnormalities were present in 83% of children at study entry. Relative to the antibiotics‐only group, in the surgical plus antibiotic treatment group there was probably little or no increased risk of new or progressive DMSA scan abnormalities (<a href="./references#CD001532-fig-0022" title="">Analysis 2.5</a>.2 (1 study, 287 children): RR 0.97, 95% CI 0.58 to 1.62) or of deterioration in DMSA scan appearance between five to 10 years (<a href="./references#CD001532-fig-0022" title="">Analysis 2.5</a>.3 (1 study, 216 children): RR 0.71, 95% CI 0.31 to 1.58). All confidence intervals included the point of no effect. </p> <p>Renal growth was evaluated in four studies (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>) at two to 10 years by measurements of changes in renal length standard deviation score (SDS) (3 studies, 510 children) or renal area (1 study, 82 children) on IVP. No real differences between groups were found at any time point or in any age group. Combining data in meta‐analysis was not possible because of differences in reporting. </p> </section> <section id="CD001532-sec-0088"> <h5 class="title">ESKD and hypertension</h5> <p>The two outcomes of greatest clinical importance, ESKD and hypertension, were reported in three studies (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>). Six children developed ESKD and 14 developed hypertension during follow‐up. It is uncertain whether surgical correction plus antibiotics compared with antibiotics alone reduced the risk for ESKD at five years (<a href="./references#CD001532-fig-0024" title="">Analysis 2.7</a>.1 (2 studies, 154 children): RR 1.07, 95% CI 0.23 to 5.04; I<sup>2</sup> = 0%; very low certainty evidence) or of hypertension overall (<a href="./references#CD001532-fig-0024" title="">Analysis 2.7</a>.2 (2 studies, 154 children): RR 0.93, 95% CI 0.25 to 3.42; I2 = 13%; very low certainty evidence), or for hypertension at 10 years (<a href="./references#CD001532-fig-0024" title="">Analysis 2.7</a>.3 (1 study, 252 children): RR 0.15, 95% CI 0.01 to 2.78). Studies were small and imprecise and all confidence intervals were wide and crossed the point of no effect. </p> </section> <section id="CD001532-sec-0089"> <h5 class="title">GFR</h5> <p>Four studies (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0023" title="MorrisMC , RothwellDL , PaykelAD . A prospective study of vesico‐ureteric reflux and renal function in children. 2nd CJ Hodson Symposium on Reflux Nephropathy; 1991 Feb 26; Christchurch, NZ. 1991:61‐2. [CENTRAL: CN‐00602103] ">Morris 1991</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>) reported on GFR but these were unable to be combined because of insufficiently reported point estimate and variance data. Individually, no study reported any differences between groups. Data from <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a> showed no differences in GFR measured by the Schwartz formula at study entry (<a href="./references#CD001532-fig-0025" title="">Analysis 2.8</a>.1), at five years (<a href="./references#CD001532-fig-0025" title="">Analysis 2.8</a>.2) and at 10 years (<a href="./references#CD001532-fig-0025" title="">Analysis 2.8</a>.3). </p> </section> <section id="CD001532-sec-0090"> <h5 class="title">Height</h5> <p>Growth was investigated in <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>. There was no difference in height SDS at study entry (<a href="./references#CD001532-fig-0026" title="">Analysis 2.9</a>.1) or at 10 years (<a href="./references#CD001532-fig-0026" title="">Analysis 2.9</a>.2). </p> </section> <section id="CD001532-sec-0091"> <h5 class="title">Correction of VUR</h5> <p>Resolution of VUR was an outcome described in five studies (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>;). We could not combine individual study data for the surgical studies because of differences in reporting practices (patients and ureters), not all patients having had follow‐up VCUGs and missing data. In four studies (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>) the postoperative resolution rate at four to five years for ureters was 93% to 99%. Over a follow‐up period of three to five years, 16% to 49% of patients had spontaneous resolution of VUR (<a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a>; <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>; <a href="./references#CD001532-bbs2-0016" title="ArantBSJr . Vesicoureteral reflux and evidence‐based management. Journal of Pediatrics2001;139(5):620‐1. [MEDLINE: 11713435] DuckettJW , WalkerRD , WeissR . Surgical results: International Reflux Study in Children‐‐United States branch. Journal of Urology1992;148(5 Pt 2):1674‐5. [MEDLINE: 1433586] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical (m) vs surgical (s) management of infants &amp; children with primary grades III &amp; IV vesico‐ureteral reflux (VUR) [abstract no: 11P]. Journal of the American Society of Nephrology1992;3(3):290. [CENTRAL: CN‐00461981] WeissR , DuckettJ , SpitzerA . Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1667‐73. [MEDLINE: 1433585] WeissR , Tamminen‐MobiusT , KoskimiesO , OlbingH , SmellieJM , HircheH , et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1644‐9. [MEDLINE: 1433580] ">IRS USA 1992</a>; <a href="./references#CD001532-bbs2-0032" title="BarrattTM , ChantlerC , PrescodNP , WoolfAS , SmellieJM . Randomised trial comparing medical and surgical treatment in children with bilateral vesicoureteric reflux and nephropathy [abstract]. Renal Association 50th Anniversary Meeting; 2000 Sep 27‐29; St John College, Cambridge, UK. 2000. RoseauE . Vesico‐ureteral reflux and nephropathy in the child: medical or surgical treatment? [Reflux vesico‐ureteral et nephropathie de l'enfant: traitement medical ou chirurgical?]. Presse Medicale2001;30(23):1157‐8. [MEDLINE: 11505836] SmellieJM , BarrattTM , ChantlerC , GordonI , PrescodNP , RansleyPG , et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet2001;357(9265):1329‐33. [MEDLINE: 11343739] ">Smellie 2001</a>; <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>). In <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a>, 130/155 children in the antibiotics‐only group had persisting VUR at five years though in 50 other children VUR grade had diminished. Among 102 children undergoing voiding VCUGs at 10 years, VUR was still present in 27 children (22 with grade IV and five with grade III). In <a href="./references#CD001532-bbs2-0031" title="ScottJE , StansfeldJM . Treatment of vesico‐ureteric reflux in children. Archives of Disease in Childhood1968;43(229):323‐8. [MEDLINE: 5652710] ">Scott 1968</a>, 6/31 had persistent VUR three years postoperatively (very low certainty evidence) and 4/31 had successful operations, but developed VUR in the opposite ureter at a later date. </p> </section> <section id="CD001532-sec-0092"> <h5 class="title">Adverse events</h5> <p>Adverse events for either group were generally not well reported. Postoperative obstruction to the urinary tract occurred in 7% of children (10/151) in the <a href="./references#CD001532-bbs2-0015" title="Comparison of conservative and surgical treatment of the vesico‐uretero‐renal reflux. International prospective reflux study in children [Vergleich von medikamentoser und chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen reflux]. Urologe. Ausgabe A1981;20(2):107‐15. [MEDLINE: 7025416] HjalmasK , LohrG , Tamminen‐MobiusT , SeppanenJ , OlbingH , WikstromS . Surgical results in the International Reflux Study in Children (Europe). Journal of Urology1992;148(5 Pt 2):1657‐61. [MEDLINE: 1433583] JodalU , KoskimiesO , HansonE , LohrG , OlbingH , SmellieJ , et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long‐term antibacterial prophylaxis. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1650‐2. [MEDLINE: 1433581] JodalU , SmellieJM , LaxH , HoyerPF . Ten‐year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatric Nephrology2006;21(6):785‐92. [MEDLINE: 16565873] OlbingH . Comparison of the surgical and nonsurgical treatment of primary vesico‐ureteral‐renal reflux‐‐an international reflux study [Vergleich von chirurgischer und nicht‐chirurgischer Behandlung beim primaren vesiko‐uretero‐renalen Reflux‐‐Internationale Refluxstudie]. Kinderarztliche Praxis1986;54(9):493‐9. [MEDLINE: 3540424] OlbingH . Risk‐oriented recommendations for the management of children with dilating primary vesico‐ureteral reflux ‐ report of the International Reflux Study 1 children (IRSC) ‐ European branch [abstract]. 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 ‐ Sep 4; Jerusalem, Israel. 1992:C37‐C8. OlbingH , ClaessonI , EbelKD , SeppanenU , SmellieJM , Tamminen‐MobiusT , et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5‐year report of the International Reflux Study in Children (European branch). Journal of Urology1992;148(5 Pt 2):1653‐6. [MEDLINE: 1433582] OlbingH , HircheH , KoskimiesO , LaxH , SeppanenU , SmellieJM , et al. Renal growth in children with severe vesicoureteral reflux: 10‐year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology2000;216(3):731‐7. [MEDLINE: 10966703] OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] OlbingH , Tamminen‐MöbiusT , International Reflux Study in Europe. International reflux study patients with stable and unstable vesicoureteral reflux during pre‐allocation period [abstract no: W9‐2]. Pediatric Nephrology1987;1(1):C19. [CENTRAL: CN‐00447018] PiepszA , Tamminen‐MobiusT , ReinersC , HeikkilaJ , KivisaariA , NilssonNJ , et al. Five‐year study of medical or surgical treatment in children with severe vesico‐ureteral reflux dimercaptosuccinic acid findings. International Reflux Study Group in Europe. European Journal of Pediatrics1998;157(9):753‐8. [MEDLINE: 9776536] SmellieJM . The International Reflux Study in Children: an update. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:88‐91. SmellieJM , JodalU , LaxH , MobiusTT , HircheH , OlbingH , et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. Journal of Pediatrics2001;139(5):656‐63. [MEDLINE: 11713442] SmellieJM , Tamminen‐MobiusT , OlbingH , ClaessonI , WikstadI , JodalU , et al. Radiologic findings in the kidney of children with severe reflux. Five‐year comparative study of conservative and surgical treatment [Radiologische Nierenbefunde bei Kindern mit schwerem Reflux. Funfjahresvergleichsstudie konservativer und chirurgischer Behandlung]. Urologe ‐ Ausgabe A1993;32(1):22‐9. [MEDLINE: 8447041] SmellieJM , Tamminen‐MöbiusT , OlbingH , ClaëssonI , WikstadI , JodalU , et al. Five‐year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatric Nephrology1992;6(3):223‐30. [MEDLINE: 1616829] Tamminen‐MobiusT , BrunierE , EbelKD , LebowitzR , OlbingH , SeppanenU , et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. Journal of Urology1992;148(5 Pt 2):1662‐6. [MEDLINE: 1433584] WingenAM , KoskimiesO , OlbingH , SeppanenJ , Tamminen‐MobiusT . Growth and weight gain in children with vesicoureteral reflux receiving medical versus surgical treatment: 10‐year results of a prospective, randomized study. International Reflux Study in Children (European Branch). Acta Paediatrica1999;88(1):56‐61. [MEDLINE: 10090549] ">IRS EUR 1981‐2003</a> study. The <a href="./references#CD001532-bbs2-0002" title="A prospective trial of operative versus non‐operative treatment of severe vesico‐ureteric reflux: 2 years' observation in 96 children. The Birmingham Reflux Study Group. Contributions to Nephrology1984;39:169‐85. [MEDLINE: 6744870] Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux: two years observation in 96 children. British Medical Journal Clinical Research Ed1983;287(6386):171‐4. [MEDLINE: 6409239] CorkeryJJ , GornallP , ShahKJ , TaylorCM , WhiteRHR , WinterbornMH . Prospective trial of operative versus non‐operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. British Medical Journal Clinical Research Ed1987;295(6592):237‐41. [MEDLINE: 2888509] TaylorCM , WhiteR , WinterbornMH , ShahKJ , CorkeryJJ , GornallP . Medical versus surgical management ‐ the Birmingham study five years on. Proceedings of the 1st CJ Hodson Symposium on Reflux Nephropathy; 1987 Mar 5‐6; Melbourne, Australia. 1987:79‐87. ">BIRSG 1983</a> study stated that no cases of postoperative obstruction were found after five years. The authors did report six other adverse events. One boy had transient ureteral and renal pelvic dilatation on ultrasound at one month, one boy developed urine retention after endoscopic injection, and one boy aspirated during anaesthesia and required overnight observation in the intensive care unit. One girl suffered abdominal pain with pelvic dilatation and decreasing kidney split function. The authors stated this resulted from a crossing vessel at the pelviureteral junction and was not related to the intervention. Finally, in one boy a fibrous narrowing of the bulbar urethra without obstruction was detected during the first endoscopic procedure. A weakening urine stream and obstructive flow curve pattern led to repeat endoscopic investigation, which revealed deterioration of bulbar narrowing. Ultimately internal urethrotomy was done. No other study referred to obstruction. No other adverse outcomes of surgery were reported. </p> <p>No study reported on whether bacterial resistance developed to the prophylactic drug in subsequent symptomatic UTIs </p> </section> </section> <section id="CD001532-sec-0093"> <h4 class="title">Surgical reimplantation type 1 versus surgical reimplantation type 2</h4> <p>One study of 30 children (<a href="./references#CD001532-bbs2-0017" title="KojimaY , MizunoK , UmemotoY , YasuiT , HayashiY , KohriK . Ureteral advancement in patients undergoing laparoscopic extravesical ureteral reimplantation for treatment of vesicoureteral reflux. Journal of Urology2012;188(2):582‐7. [MEDLINE: 22704095] ">Kojima 2012</a>) compared surgical reimplantation‐advancement technique with surgical reimplantation‐no advancement technique and reported the outcomes repeat positive urine culture, persistent VUR and perioperative complications. Little or no differences were seen in any outcomes (<a href="./references#CD001532-fig-0029" title="">Analysis 3.1</a>; <a href="./references#CD001532-fig-0030" title="">Analysis 3.2</a>; <a href="./references#CD001532-fig-0031" title="">Analysis 3.3</a>). </p> </section> <section id="CD001532-sec-0094"> <h4 class="title">Endoscopic injection treatment with/without antibiotics versus antibiotics alone</h4> <p>See <a href="./full#CD001532-tbl-0003">summary of findings Table 3</a>. </p> <section id="CD001532-sec-0095"> <h5 class="title">Urinary tract infection</h5> <section id="CD001532-sec-0096"> <h6 class="title">Symptomatic and febrile UTI</h6> <p>Three studies (<a href="./references#CD001532-bbs2-0005" title="DiteZ , KocvaraR , DvoracekJ , LangerJ , SedlacekJ . Endoscopic and conservative treatment of vesicoureteric reflux [Endoskopicka a konzervativni lecba vezikoureteralniho refluxu]. Casopis Lekaru Ceskych2007;146(10):817‐21. [MEDLINE: 18020019] ">Dite 2007</a>; <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>) compared endoscopic injection with antibiotic prophylaxis and reported the outcomes of repeat symptomatic UTI and febrile UTI. Compared with antibiotics alone, endoscopic correction of VUR may lead to little or no reduction in the risk of symptomatic UTI (<a href="./references#CD001532-fig-0032" title="">Analysis 4.1</a>.1 (3 studies, 254 participants): RR 0.80, 95% CI 0.37 to 1.75; I<sup>2</sup> = 58%; low certainty evidence) and in the risk of febrile UTI (<a href="./references#CD001532-fig-0032" title="">Analysis 4.1</a>.2 (3 studies, 254 participants): RR 0.74 95% CI 0.31 to 1.78; I<sup>2</sup> = 58%; low certainty evidence). The three studies included only 254 children and may reflect chance events. Assessment of these studies showed many study design fields of unclear or high bias and they were small studies with few events and large imprecision. </p> </section> <section id="CD001532-sec-0097"> <h6 class="title">Repeat positive urine culture</h6> <p>One study (<a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>), involving 60 children, reported the outcome of repeat positive urine culture with a very imprecise estimate that cannot be used to guide clinical decisions (<a href="./references#CD001532-fig-0032" title="">Analysis 4.1</a>.3 (1 study, 60 participants) RR 7.15 95% CI 0.42 to 121.04; very low certainty evidence). </p> </section> </section> <section id="CD001532-sec-0098"> <h5 class="title">Renal parenchymal abnormality</h5> <p>Two studies (<a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a>; <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>) reported the outcome of renal parenchymal defects on DMSA scan. Compared with antibiotic prophylaxis, endoscopic correction of VUR may make little or no difference to the number of children with new or deteriorating renal damage on DMSA scan (<a href="./references#CD001532-fig-0033" title="">Analysis 4.2</a>.1 (2 studies, 208 participants): RR 1.20, 95% CI 0.36 to 3.96; I<sup>2</sup> = 45%; low certainty evidence). The inconsistency, bias and small sample size with few events in these studies leads to an assessment of low certainty evidence. One study (<a href="./references#CD001532-bbs2-0003" title="CapozzaN , CaioneP . Dextranomer/hyaluronic acid copolymer implantation for vesico‐ureteral reflux: a randomized comparison with antibiotic prophylaxis. Journal of Pediatrics2002;140(2):230‐4. [MEDLINE: 11865276] ">Capozza 2002</a>) measured renal damage using ultrasound and reported a very imprecise estimate of treatment effect (<a href="./references#CD001532-fig-0034" title="">Analysis 4.3</a>.1 (1 study, 81 participants: RR 0.34 95% CI 0.04, 3.31) for new renal parenchymal defects </p> </section> <section id="CD001532-sec-0099"> <h5 class="title">Correction of VUR</h5> <p>Compared with antibiotics alone, more children in the endoscopic group may have full resolution of VUR after one to two years (<a href="./references#CD001532-fig-0035" title="">Analysis 4.4</a>.1 (2 studies, 164 children): RR 2.69, 95% CI 1.57 to 4.63) and improvement in VUR grade (<a href="./references#CD001532-fig-0035" title="">Analysis 4.4</a>.2 (3 studies, 238 children): RR 2.01 95% CI 1.51 to 2.68; I<sup>2</sup> = 0%; low certainty evidence). Assessment of these studies showed many study design fields with high or unclear levels of bias and the studies were small and imprecise, leading to the conclusion this is low certainty evidence </p> </section> <section id="CD001532-sec-0100"> <h5 class="title">Microbial resistance to the prophylactic drug</h5> <p>Only <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a> reported microbial resistance to the treatment antibiotic and showed little or no difference between the groups in the number of UTIs caused by pathogens resistant to the antibiotic being used for prophylaxis (<a href="./references#CD001532-fig-0036" title="">Analysis 4.5</a>; RR 0.63 95% CI 0.34 to 1.15; very low certainty evidence), This finding is not surprising given that both groups were taking antibiotics. </p> </section> <section id="CD001532-sec-0101"> <h5 class="title">Adverse events</h5> <p>None of the children treated with endoscopic injection in <a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a> experienced vesicoureteric obstruction but three experienced post‐operative complications. Three children in the antibiotic group and none in the endoscopic treatment group within the <a href="./references#CD001532-bbs2-0024" title="NordenstromJ , HolmdahlG , BrandstromP , SixtR , StoklandE , SillenU , et al. The Swedish infant high‐grade reflux trial: Study presentation and vesicoureteral reflux outcome. Journal of Pediatric Urology2016;13(2):130‐8. [MEDLINE: 27889221] NordenstromJ , HolmdahlG , SillenU , SixtR , StoklandE , SjostromS . The Swedish infant high grade reflux trial‐VUR grade and bladder function [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033229] NordenstromJ , SillenU , HolmdahlG , LinnerT , StoklandE , SjostromS . The Swedish Infant High‐grade Reflux Trial ‐ bladder function. Journal of Pediatric Urology2016;13(2):139‐45. [MEDLINE: 27989639] NordenstromJ , SjostromS , SillenU , SixtR , BrandstromP . The Swedish infant high grade reflux trial: UTI and renal damage. Journal of Pediatric Urology2017;13(2):146‐54. [MEDLINE: 28215835] NordenstromJ , SjostromS , SixtR , SillenU , BrandstromP . The Swedish infant high grade reflux trial‐UTI and renal damage [abstract]. Pediatric Nephrology2015;30(9):1565. [EMBASE: 72033228] NordenströmJ , SillénS , BrandströmP , HanssonS , HolmdahlG , LinnérT , et al. The Swedish Infant High Grade Reflux Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:12. ">Nordenstrom 2016</a> study experienced nausea and vomiting while on treatment. </p> </section> <section id="CD001532-sec-0102"> <h5 class="title">Other outcomes</h5> <p>ESKD and hypertension were not reported.</p> </section> </section> <section id="CD001532-sec-0103"> <h4 class="title">Endoscopic injection treatment versus no treatment</h4> <section id="CD001532-sec-0104"> <h5 class="title">Urinary tract infection</h5> <section id="CD001532-sec-0105"> <h6 class="title">Symptomatic and febrile UTI</h6> <p><a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a> involved three study arms which allows for a comparison between endoscopic injection treatment and no treatment. Compared with no treatment, endoscopic correction of VUR may reduce the risk for symptomatic and febrile UTI (<a href="./references#CD001532-fig-0037" title="">Analysis 5.1</a>. (1 study; 134 participants): RR 0.55 95% CI 0.33 to 0.94 and <a href="./references#CD001532-fig-0038" title="">Analysis 5.2</a>, (1 study, 134 participants): RR 0.52 95% CI 0.30 to 0.89). Since only 134 children were studied this may represent a chance effect. </p> </section> </section> <section id="CD001532-sec-0106"> <h5 class="title">Renal parenchymal abnormality</h5> <p><a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>,compared with no treatment, endoscopic correction of VUR may make little of no difference to the risk for renal parenchymal defects (<a href="./references#CD001532-fig-0039" title="">Analysis 5.3</a> (1 study, 133 participants): RR 0.70, 95% CI 0.3 to 1.6). </p> </section> <section id="CD001532-sec-0107"> <h5 class="title">Other outcomes</h5> <p>Resolution of VUR, ESKD, hypertension, and adverse events were not reported.</p> </section> </section> <section id="CD001532-sec-0108"> <h4 class="title">Different materials for subureteric injection to correct VUR</h4> <p>See <a href="./full#CD001532-tbl-0004">summary of findings Table 4</a>. </p> <p>Four studies compared two different products for endoscopic injection to correct VUR, Two studies (<a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a>; <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a>) compared endoscopic subureteric injections of Macroplastique with Deflux but these were dissimilar in that <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a> compared these in children also taking prophylactic antibiotics. <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a> showed no difference in the number of febrile UTIs across the two treatment groups and <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a> reported no difference in afebrile UTIs between the two groups. For the outcome of persistent VUR both studies favoured Macroplastique with a 50% reduction in risk of persistent VUR at three months (<a href="./references#CD001532-fig-0040" title="">Analysis 6.1</a>.3 (2 studies, 513 participants): RR 0.50, 95% CI 0.33 to 0.78; I<sup>2</sup> = 0%) and a 46% reduction in risk at 12 months (<a href="./references#CD001532-fig-0040" title="">Analysis 6.1</a>.4 (2 studies, 472 participants): RR 0.54 (95% CI 0.35 to 0.83; I<sup>2</sup> = 0%). Assessment of these studies found study design fields of unclear or high risk of bias indicating that subureteric injection with Macroplastique compared with dextranomer hyaluronic acid polymer probably reduces the risk for persistent VUR (moderate certainty evidence). <a href="./references#CD001532-bbs2-0025" title="OswaldJ , RiccabonaM , LusuardiL , BartschG , RadmayrC . Prospective comparison and 1‐year follow‐up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology2002;60(5):894‐7. [MEDLINE: 12429323] ">Oswald 2002</a> reported a moderately higher risk of temporary pelvicaliceal dilatation with Macroplastique (<a href="./references#CD001532-fig-0040" title="">Analysis 6.1</a>.5 (114 participants): RR 1.85, 95% CI 1.02 to 3.35; low certainty evidence). <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a> reported three cases of ureteral obstruction in the Macroplastique group compared with two cases in the Deflux group (low certainty evidence). There were four cases of flank pain after injection in the Macroplastique compared with three cases in the Deflux group of <a href="./references#CD001532-bbs2-0022" title="MooreK , BolducS . Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Journal of Urology2014;192(6):1794‐9. [MEDLINE: 24928269] ">Moore 2014</a> (low certainty evidence). </p> <p>No data on renal parenchymal abnormalities were reported.</p> <p>One small study of 28 children (<a href="./references#CD001532-bbs2-0008" title="FreyP , GudinchetF , JennyP . GAX 65: new injectable cross‐linked collagen for the endoscopic treatment of vesicoureteral reflux‐‐a double‐blind study evaluating its efficiency in children. Journal of Urology1997;158(3 Pt 2):1210‐2. [MEDLINE: 9258175] ">Frey 1997</a>) compared endoscopic subureteric injections of different concentrations of GAX 65 and GAX 35. VUR was five times more likely to persist following GAX 35 than GAX 65 injections (<a href="./references#CD001532-fig-0041" title="">Analysis 6.2</a>.1 (28 children): RR 0.21, 95% CI 0.05 to 0.85). The estimated risk of recurrence of VUR between therapies was imprecise (<a href="./references#CD001532-fig-0041" title="">Analysis 6.2</a>.2 (1 study, 28 children)<i>:</i> RR 0.30, 95% CI 0.07 to 1.29). No data on UTIs or renal parenchymal abnormalities were reported. This study represents very low certainty evidence. </p> <p><a href="./references#CD001532-bbs2-0012" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexcel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children [abstract]. European Urology Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a> compared dextranomer hyaluronic acid polymer with polyacrylate polyalcohol bulking polymer (Vantris). UTIs were not reported. Different bulking agents may lead to little or no difference in risk of repeat positive urine culture, fever, persistence of VUR or ureteral obstruction (<a href="./references#CD001532-fig-0042" title="">Analysis 6.3</a>.1 to <a href="./references#CD001532-fig-0042" title="">Analysis 6.3</a>.4) (low certainty evidence). </p> </section> <section id="CD001532-sec-0109"> <h4 class="title">Probiotic versus antibiotic prophylaxis</h4> <p>See <a href="./full#CD001532-tbl-0005">summary of findings Table 5</a>. </p> <p>Two studies (<a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>) compared the potential benefits and harms of probiotic versus antibiotic prophylaxis in single centre studies and included 120 and 128 children respectively. Compared with antibiotic prophylaxis, probiotics may make little or no difference in risk of repeat symptomatic UTI (<a href="./references#CD001532-fig-0043" title="">Analysis 7.1</a>.1 (1 study, 24 children): RR 0.82, 95% CI 0.56 to 1.21) and febrile UTI at one year (<a href="./references#CD001532-fig-0043" title="">Analysis 7.1</a>.2 (1 study, 24 children): RR 0.82, 95% CI 0.37 to 1.83; low certainty evidence). Assessment of these two studies showed there were many study design fields with high or unclear risk of bias, the studies were small and imprecise, leading to the conclusion there is low certainty in this evidence. In <a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a> by the end of the one year follow‐up period, 2 of 13 patients in the antibiotics group had experienced a repeat UTI and had developed a new renal scar, versus 1 of 11 in the probiotics group. In <a href="./references#CD001532-bbs2-0018" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP.81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a> seven symptomatic UTI recurrences (64%) had <i>Escherichia coli</i> identified as the causative organism in the probiotics group versus nine (69%) in the antibiotics group. These data were not available for <a href="./references#CD001532-bbs2-0019" title="LeeSJ , LeeJW . Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatric Nephrology2015;30(4):609‐13. [MEDLINE: 25354903] LeeSJ , LeeM . Probiotics versus antibiotic prophylaxis in infants with primary vesicoureteral reflux [abstract no: 285]. Pediatric Nephrology2010;25(9):1852. ">Lee 2015</a>. Across the two studies, six of the 18 repeat UTIs caused by <i>E.coli</i> in the probiotic group were resistant to trimethoprim‐sulphamethoxazole while 20/20 <i>E. coli</i> infections were resistant to the treatment drug in the antibiotic group (<a href="./references#CD001532-fig-0044" title="">Analysis 7.2</a> (RR 0.38, 95% CI 0.21 to 0.69)(RR 0.38, 95% CI 0.21 to 0.69; I<sup>2</sup> = 0%). Compared with antibiotic prophylaxis, probiotics may make little or no difference to the risk of renal parenchymal abnormality (<a href="./references#CD001532-fig-0045" title="">Analysis 7.3</a>.1 (2 studies, 152 participants): RR 0.69, 95% CI 0.43 to 1.11; I<sup>2</sup> = 0%; low certainty evidence). These studies do not provide evidence of sufficient certainty to support clinical decisions on the efficacy of probiotics to prevent UTI in children. </p> <p>A single study of 85 children compared probiotics plus antibiotics with antibiotics alone (<a href="./references#CD001532-bbs2-0020" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>). No difference between treatment groups was seen for the outcomes repeat febrile UTI, repeat positive urine culture, new DMSA changes, microbial resistance and adverse effects (<a href="./references#CD001532-fig-0046" title="">Analysis 7.4</a>). </p> <p>ESKD, hypertension, resolution of VUR, and adverse events were not reported.</p> </section> <section id="CD001532-sec-0110"> <h4 class="title">Other Interventions</h4> <section id="CD001532-sec-0111"> <h5 class="title">Surgical reimplantation versus endoscopic treatment</h5> <p>A single small scale study (<a href="./references#CD001532-bbs2-0009" title="Garcia‐AparicioL , RoviraJ , Blazquez‐GomezE , Garcia‐GarciaL , Gimenez‐LlortA , RodoJ , et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long‐term results. Journal of Pediatric Urology2013;9(4):483‐7. [MEDLINE: 23602843] ">Garcia‐Aparicio 2013</a>) compared surgical reimplantation (Cohens technique) with endoscopic injection of dextranomer hyaluronic acid polymer in 41 children. Compared with endoscopic treatment, surgical implantation may make little or no difference in outcomes of repeat positive urine culture, VUR resolution or complications of the procedures were seen between the surgical and endoscopic treatment groups (<a href="./references#CD001532-fig-0047" title="">Analysis 8.1</a>) (low certainty evidence). </p> </section> <section id="CD001532-sec-0112"> <h5 class="title">Cranberry products</h5> <p>A study of 76 children (<a href="./references#CD001532-bbs2-0006" title="DotisJ , PrintzaN , StabouliS , PavlakiA , SamaraS , PapachristouF . Efficasy of cranberry capsules to prevent recurrences of urinary tract infections [abstract no: P351]. Pediatric Nephrology2014;29(9):1793‐4. [EMBASE: 71662748] ">Dotis 2014</a>) compared cranberry capsules with no treatment and found repeat positive urine culture was more frequent in the no treatment arm (<a href="./references#CD001532-fig-0048" title="">Analysis 8.2</a> (1 study, 76 participants): RR 0.29 95% CI 0.14 to 0.59). It is uncertain whether cranberry capsules compared with no treatment prevents UTI since the certainty of the evidence is very low. </p> </section> <section id="CD001532-sec-0113"> <h5 class="title">Circumcision</h5> <p><a href="./references#CD001532-bbs2-0011" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a> compared circumcision plus antibiotics to antibiotics alone in 91 boys with VUR. Repeat positive urine culture was less frequent in the circumcision group (<a href="./references#CD001532-fig-0049" title="">Analysis 8.3</a>.2; (91 participants): RR 0.28 95% CI 0.12 to 0.70) but symptomatic UTI and DMSA changes showed no differences across treatment groups (<a href="./references#CD001532-fig-0049" title="">Analysis 8.3</a>.1; <a href="./references#CD001532-fig-0049" title="">Analysis 8.3</a>.3). From this single RCT, it remains uncertain whether circumcision plus antibiotics prevents UTI since the certainty of this evidence is very low (very low certainty evidence). </p> </section> <section id="CD001532-sec-0114"> <h5 class="title">Oxybutynin</h5> <p><a href="./references#CD001532-bbs2-0001" title="AhnSH , ChoiHR , ChoSJ , LeeSJ . The effect of oxybutynin on spontaneous resolution of primary vesicoureteral reflux in children [abstract no: FC9‐02]. Nephrology2003;8(Suppl 1):A24. AhnSH , ShimSY , LeeJW , ChoSJ , LeeSJ . The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux. Journal of the Korean Society of Pediatric Nephrology2003;7(2):174‐80. [CENTRAL: CN‐01044096] ">Ahn 2003</a> compared the anticholinergic, Oxybutynin, with placebo for the outcome resolution of VUR at 12 months. 38/56 (67.9%) children treated with oxybutynin had resolution or improvement of their VUR grade while 57/93 (61.3%) children in the placebo group showed an improved or resolved VUR grade after 12 months (<a href="./references#CD001532-fig-0050" title="">Analysis 8.4</a>). Oxybutynin compared with placebo may make little or no difference to the improvement in VUR (low certainty evidence). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001532-sec-0115" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001532-sec-0115"></div> <section id="CD001532-sec-0116"> <h3 class="title" id="CD001532-sec-0116">Summary of main results</h3> <p>The benefits and harms of interventions for primary VUR were assessed in 34 studies involving 4001 children. </p> <section id="CD001532-sec-0117"> <h4 class="title">Antibiotic prophylaxis versus surveillance/no treatment</h4> <p>Twelve studies comparing long‐term low‐dose antibiotic prophylaxis with placebo or no treatment were identified. Although the pooled estimate of risk of repeat symptomatic and febrile UTI favoured antibiotic treatment, precision was poor and included no difference between treatment groups. Overall, long‐term low‐dose antibiotic prophylaxis may make little or no difference to the number of children who experience repeat symptomatic or febrile UTI (low certainty evidence) or to the number of children, developing new or progressive renal damage compared with placebo or no treatment (low certainty evidence) (<a href="./full#CD001532-tbl-0001">summary of findings Table for the main comparison</a>). Three studies were at low risk of bias across all study design fields and when only these three studies were considered, antibiotic prophylaxis made little or no difference to the likelihood of further UTIs (moderate certainty evidence) (<a href="./full#CD001532-tbl-0001">summary of findings Table for the main comparison</a>). Side effects of the preventive treatment were minor and infrequent but poorly reported (low certainty evidence) (<a href="./full#CD001532-tbl-0001">summary of findings Table for the main comparison</a>.) Little data were provided as to how side‐effects had affected adherence. Reported compliance rates varied between 70% and 100%, but they were inconsistently measured. Since previous studies have shown poor compliance for daily antibiotic regimens for VUR (<a href="./references#CD001532-bbs2-0046" title="CohenAL , RivaraFP , DavisR , ChristakisDA . Compliance with guidelines for the medical care of first urinary tract infections in infants: a population based study. Pediatrics2005;115(6):1474‐8. [MEDLINE: 15930206] ">Cohen 2005</a>; <a href="./references#CD001532-bbs2-0049" title="GreenfieldSP , NgM , WanJ . Experience with vesicoureteral reflux in children: clinical characteristics. Journal of Urology1997;158(2):574‐7. [MEDLINE: 9224365] ">Greenfield 1997</a>), it raises the question whether antibiotics were inherently ineffective or were not being used as prescribed. Treating VUR patients with long‐term low‐dose antibiotics probably increases the risk of microbial resistance against the prophylactic drug in breakthrough infections (moderate certainty evidence) (<a href="./full#CD001532-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD001532-sec-0118"> <h4 class="title">Surgical reimplantation of ureters plus antibiotics (1 to 24 months) versus antibiotics alone </h4> <p>Only the European arm of the IRS study evaluated the differential risk of any symptomatic UTI between medical and surgical treatment and found that by four to five years, there was little or no difference in symptomatic UTI. Both the European and the American arms of the IRS study however, investigated the risk of febrile UTI and found a significant benefit for those children who underwent surgical VUR correction. Assuming a baseline risk of 22% of developing febrile UTI when on antibiotics alone the estimated risk translates into a risk difference of 13% so that eight patients need surgery to prevent one extra febrile UTI over five years. T. Further analysis at 10 years confirmed these results. It supports the idea that although surgery might not provide an added benefit over antibiotic prophylaxis in preventing symptomatic lower UTI, it might keep the infection from spreading to the upper tract, and ultimately prevent subsequent renal damage. No evidence was found to corroborate this theory however, since the risk of developing new or progressive renal damage at five and 10 years was no different between the treatment groups. Although no differences between treatment groups were demonstrated for hypertension or end stage kidney disease, <b>i</b>t remains uncertain whether surgical correction of VUR influences the risk of hypertension and CKD because the certainty of this evidence is very low (<a href="./full#CD001532-tbl-0002">summary of findings Table 2</a>). </p> <p>Potential benefits of surgery need to be weighed against its potential adverse effects. Whereas the Birmingham Reflux Study stated that no cases of postoperative obstruction were found after five years, they occurred in 7% of children (10/151) in the European arm of the International Reflux Study, corresponding to one every 14 to 15 patients undergoing the procedure. </p> </section> <section id="CD001532-sec-0119"> <h4 class="title">Endoscopic injection treatment for VUR correction</h4> <p>If VUR correction were beneficial, endoscopic subureteric injection of various materials could offer an alternative method to open surgery for correcting VUR. Eight studies included in this review used endoscopic injection in at least one study group, and these have demonstrated VUR correction rates of 70% to 90%. However when compared with long‐term low‐dose antibiotic prophylaxis alone, endoscopic correction with or without antibiotics may make little or no difference to the likelihood of either symptomatic, febrile UTI or progressive renal damage. Results were derived from three small studies with only 254 children leading to low certainty evidence (<a href="./full#CD001532-tbl-0003">summary of findings Table 3</a>). A single small study (<a href="./references#CD001532-bbs2-0033" title="BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish Reflux Trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish Reflux Trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] BrandströmP . Swedish Reflux Trial – a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish Reflux Trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish Reflux Trial in children: V. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux Trial 2010</a>) found that fewer children following endoscopic correction of VUR developed UTI compared to no treatment. </p> <p>Four studies in this review directly compared two different materials with each other, with two suggesting that Macroplastique is superior to dextranomer/hyaluronic acid polymer for correcting reflux. However the quality, size and consistency of findings is inadequate for confident conclusions (low certainty evidence) (<a href="./full#CD001532-tbl-0004">summary of findings Table 4</a>). </p> </section> <section id="CD001532-sec-0120"> <h4 class="title">Other interventions</h4> <p>Probiotic treatment may make little or no difference to the risk of symptomatic UTI or renal damage detected by DMSA scan (low certainty evidence) (<a href="./full#CD001532-tbl-0005">summary of findings Table 5</a>). Cranberry capsules, circumcision and oxybutynin were trialled in single, small studies with each study result favouring the intervention but with limited confidence due to imprecision from small sample sizes with infrequent events, and sources of bias from sub‐optimal study designs. </p> </section> </section> <section id="CD001532-sec-0121"> <h3 class="title" id="CD001532-sec-0121">Overall completeness and applicability of evidence</h3> <p>Children with grade V reflux are generally viewed as having the highest risk of developing renal damage after pyelonephritis. However in the 12 studies of low‐dose antibiotic treatment compared with placebo or no treatment, only three included children with grade V reflux and only <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> specified the number of children (5) with grade V reflux. Most surgical reimplantation studies included participants with VUR grades II, III and IV and children with grade V VUR were excluded. Hence we cannot extrapolate the results from this review to children with VUR grade V. A randomised comparison between antibiotic treatment and surgical reimplantation alone has not been performed since in all studies, antibiotics were given to children undergoing surgery. Very few studies reported data for analysis of treatment effect within the genders and laterality of VUR, hence no conclusions could be drawn. The few small studies comparing endoscopic injection treatment of VUR with antibiotic prophylaxis are insufficient to determine whether there are real benefits for endoscopic correction over antibiotic prophylaxis or no treatment. Further studies are required to determine if probiotics or other interventions have any role in preventing UTI in children with VUR. </p> </section> <section id="CD001532-sec-0122"> <h3 class="title" id="CD001532-sec-0122">Quality of the evidence</h3> <p>The quality of conduct and reporting of these studies was variable, with many studies omitting crucial methodological information used to assess the risk of bias. Only four of the 34 studies were considered at low risk of bias across all fields of study quality (<a href="./references#CD001532-bbs2-0004" title="CraigJ , RoyL , BurkeJ , PowellH , HodsonEM , KnightJF , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: 44]. Nephrology2002;7(Suppl 3):A55. CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH , et al. Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. ">Craig 2002</a>; <a href="./references#CD001532-bbs2-0013" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363‐4. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001532-bbs2-0029" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MatooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152082. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJ . RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence Based Medicine2014;19(6):229‐30. [MEDLINE: 25189165] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>). The majority of studies had many areas of uncertainty in the risk of bias fields, reflecting missing detail rather than stated poor design. </p> <p>The overall certainty of the evidence using GRADE was considered to be low in most analyses. Only two analyses were considered to have moderate overall certainty of the evidence. </p> <p>The effect estimate of incremental benefit of surgical reimplantation was based on only two studies that included 429 patients in the analysis. Given the nature of the intervention, it was not possible to blind participants or health care providers. Unblinded studies tend to report an overestimation of treatment effects and as such bias might have played a part in producing the difference in risk of febrile UTI in favour of surgical management. </p> </section> <section id="CD001532-sec-0123"> <h3 class="title" id="CD001532-sec-0123">Potential biases in the review process</h3> <p>A comprehensive search of the Cochrane Kidney and Transplant’s Specialised Register was performed for this review thus reducing the possibility that potential eligible studies were omitted from the review. Eligible studies published after the last search date or published in congress proceedings not routinely searched could have been missed. Authors of this review are also authors of an included study (<a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>) and may have judged that study more favourably. To alleviate this concern, an independent researcher extracted risk of bias data from <a href="./references#CD001532-bbs2-0027" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: O87]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsGJ , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> and this was incorporated into the review. </p> </section> <section id="CD001532-sec-0124"> <h3 class="title" id="CD001532-sec-0124">Agreements and disagreements with other studies or reviews</h3> <p>For over five decades, scientific published work has suggested the existence of a link between recurrent UTI, VUR, and renal scarring (<a href="./references#CD001532-bbs2-0056" title="OlbingH , SmellieJM , JodalU , LaxH . New renal scars in children with severe VUR: a 10‐year study of randomized treatment. Pediatric Nephrology2003;18(11):1128‐31. [MEDLINE: 14523634] ">Olbing 2003</a>; <a href="./references#CD001532-bbs2-0060" title="SmellieJ , EdwardsD , HunterN , NormandIC , PrescodN . Vesico‐ureteric reflux and renal scarring. Kidney International ‐ Supplement1975;4:S65‐72. [MEDLINE: 1104981] ">Smellie 1975</a>; <a href="./references#CD001532-bbs2-0061" title="SmellieJM , PoultonA , PrescodNP . Retrospective study of children with renal scarring associated with reflux and urinary infection. BMJ1994;308(6938):1193‐6. [MEDLINE: 8180534] ">Smellie 1994</a>; <a href="./references#CD001532-bbs2-0062" title="SmellieJM , PrescodNP , ShawPJ , RisdonRA , BryantTN . Childhood reflux and urinary infection: a follow‐up of 10‐41 years in 226 adults. Pediatric Nephrology1998;12(9):727‐36. [MEDLINE: 9874316] ">Smellie 1998</a>). VUR has been thought to facilitate the involvement of the upper urinary tract during UTI by allowing retrograde passage of infected urine to the ureter. Subsequently all interventions have been targeted at preventing UTI‐induced damage to the kidney. Two earlier versions of this review (<a href="./references#CD001532-bbs2-0065" title="HodsonEM , WheelerDM , SmithGH , CraigJC , VimalachandraD . Interventions for primary vesicoureteric reflux. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD001532.pub3] ">Hodson 2007</a>; <a href="./references#CD001532-bbs2-0069" title="WheelerDM , VimalachandraD , HodsonEM , SmithGH , CraigJC . Interventions for primary vesicoureteric reflux. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD001532.pub2] ">Wheeler 2004</a>) were not able to provide evidence as to whether the common practice of diagnosing and treating children with VUR conferred important health benefits, since no adequately powered studies had included a no treatment arm. Since then, new studies have compared the administration of antibiotics with placebo or no treatment. Although the addition of these studies produced a risk estimate in favour of long‐term low‐dose antibiotics for preventing repeat symptomatic UTI, the imprecision of the estimate means there may be no difference in risk of repeat UTI between children taking antibiotics and those not treated. </p> <p>In this review, we have highlighted symptomatic and febrile UTI as more relevant primary end points than positive urine cultures. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001532-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD001532-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD001532-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD001532-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 1 Urinary tract infection." data-id="CD001532-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 1 Urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 2 All symptomatic UTI by 1‐2 years: allocation concealment." data-id="CD001532-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 2 All symptomatic UTI by 1‐2 years: allocation concealment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 3 All symptomatic UTI by 1‐2 years: blinding." data-id="CD001532-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 3 All symptomatic UTI by 1‐2 years: blinding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 4 Renal parenchymal abnormality on DMSA scan: unit of analysis (children)." data-id="CD001532-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 4 Renal parenchymal abnormality on DMSA scan: unit of analysis (children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 5 Resolution of VUR." data-id="CD001532-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 5 Resolution of VUR. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 6 Adverse events." data-id="CD001532-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 6 Adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 7 Microbial resistance to prophylactic drug." data-id="CD001532-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 7 Microbial resistance to prophylactic drug. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 8 GFR at 3 years." data-id="CD001532-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 8 GFR at 3 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 9 Renal growth at 3 years." data-id="CD001532-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 9 Renal growth at 3 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 10 All symptomatic UTI by 1‐2 years: addressing of incomplete outcome data." data-id="CD001532-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 10 All symptomatic UTI by 1‐2 years: addressing of incomplete outcome data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 11 Febrile UTI by 1‐2 years: allocation concealment." data-id="CD001532-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 11 Febrile UTI by 1‐2 years: allocation concealment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 12 Febrile UTI by 1‐2 years: blinding." data-id="CD001532-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 12 Febrile UTI by 1‐2 years: blinding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 13 Febrile UTI by 1‐2 years: addressing of incomplete outcome data." data-id="CD001532-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 13 Febrile UTI by 1‐2 years: addressing of incomplete outcome data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 14 Febrile UTI by 1‐2 years according to gender." data-id="CD001532-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic prophylaxis versus placebo or no treatment, Outcome 14 Febrile UTI by 1‐2 years according to gender. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 1 Urinary tract infection." data-id="CD001532-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 1 Urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 2 Renal parenchymal defects (scars and thinning) on IVP: unit of analysis (children)." data-id="CD001532-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 2 Renal parenchymal defects (scars and thinning) on IVP: unit of analysis (children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 3 Renal scars on IVP: unit of analysis (children)." data-id="CD001532-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 3 Renal scars on IVP: unit of analysis (children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 4 Repeat positive urine culture." data-id="CD001532-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 4 Repeat positive urine culture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 5 Renal parenchymal abnormalities on DMSA scan: unit of analysis (children)." data-id="CD001532-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 5 Renal parenchymal abnormalities on DMSA scan: unit of analysis (children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 6 Renal parenchymal defects on IVP: unit of analysis (kidneys)." data-id="CD001532-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 6 Renal parenchymal defects on IVP: unit of analysis (kidneys). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 7 Hypertension and ESKD." data-id="CD001532-fig-0024" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 7 Hypertension and ESKD. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 8 GFR measured by Schwartz formula." data-id="CD001532-fig-0025" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 8 GFR measured by Schwartz formula. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 9 Height Standard Deviation Score (SDS)." data-id="CD001532-fig-0026" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 9 Height Standard Deviation Score (SDS). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 10 Correction of VUR: unit of analysis (children)." data-id="CD001532-fig-0027" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 10 Correction of VUR: unit of analysis (children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 11 Correction of VUR: unit of analysis (ureters)." data-id="CD001532-fig-0028" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Surgical reimplantation of ureters plus antibiotics versus antibiotics alone, Outcome 11 Correction of VUR: unit of analysis (ureters). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Surgical reimplantation type 1 versus surgical reimplantation type 2, Outcome 1 Repeat positive urine culture." data-id="CD001532-fig-0029" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Surgical reimplantation type 1 versus surgical reimplantation type 2, Outcome 1 Repeat positive urine culture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Surgical reimplantation type 1 versus surgical reimplantation type 2, Outcome 2 Persistent VUR (ureters)." data-id="CD001532-fig-0030" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Surgical reimplantation type 1 versus surgical reimplantation type 2, Outcome 2 Persistent VUR (ureters). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Surgical reimplantation type 1 versus surgical reimplantation type 2, Outcome 3 Peri‐operative complications." data-id="CD001532-fig-0031" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Surgical reimplantation type 1 versus surgical reimplantation type 2, Outcome 3 Peri‐operative complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Endoscopic injection treatment versus antibiotics alone, Outcome 1 Urinary tract infection." data-id="CD001532-fig-0032" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Endoscopic injection treatment versus antibiotics alone, Outcome 1 Urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Endoscopic injection treatment versus antibiotics alone, Outcome 2 Renal parenchymal abnormalities on DMSA scan: unit of analysis (children)." data-id="CD001532-fig-0033" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Endoscopic injection treatment versus antibiotics alone, Outcome 2 Renal parenchymal abnormalities on DMSA scan: unit of analysis (children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Endoscopic injection treatment versus antibiotics alone, Outcome 3 Renal damage on ultrasound." data-id="CD001532-fig-0034" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Endoscopic injection treatment versus antibiotics alone, Outcome 3 Renal damage on ultrasound. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Endoscopic injection treatment versus antibiotics alone, Outcome 4 VUR status after treatment: unit of analysis (children)." data-id="CD001532-fig-0035" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Endoscopic injection treatment versus antibiotics alone, Outcome 4 VUR status after treatment: unit of analysis (children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Endoscopic injection treatment versus antibiotics alone, Outcome 5 Microbial resistance to the prophylactic drug." data-id="CD001532-fig-0036" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Endoscopic injection treatment versus antibiotics alone, Outcome 5 Microbial resistance to the prophylactic drug. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Endoscopic injection treatment versus no treatment, Outcome 1 Symptomatic urinary tract infection." data-id="CD001532-fig-0037" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Endoscopic injection treatment versus no treatment, Outcome 1 Symptomatic urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Endoscopic injection treatment versus no treatment, Outcome 2 Febrile urinary tract infection." data-id="CD001532-fig-0038" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Endoscopic injection treatment versus no treatment, Outcome 2 Febrile urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Endoscopic injection treatment versus no treatment, Outcome 3 Renal parenchymal abnormality." data-id="CD001532-fig-0039" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Endoscopic injection treatment versus no treatment, Outcome 3 Renal parenchymal abnormality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Different materials for endoscopic injection to correct VUR, Outcome 1 Macroplastique versus dextranomer/hyaluronic acid polymer (Deflux)." data-id="CD001532-fig-0040" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Different materials for endoscopic injection to correct VUR, Outcome 1 Macroplastique versus dextranomer/hyaluronic acid polymer (Deflux). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Different materials for endoscopic injection to correct VUR, Outcome 2 GAX 65 versus GAX 35." data-id="CD001532-fig-0041" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Different materials for endoscopic injection to correct VUR, Outcome 2 GAX 65 versus GAX 35. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Different materials for endoscopic injection to correct VUR, Outcome 3 Dexcel versus Vantris." data-id="CD001532-fig-0042" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Different materials for endoscopic injection to correct VUR, Outcome 3 Dexcel versus Vantris. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Probiotics versus antibiotic prophylaxis, Outcome 1 Urinary tract infection." data-id="CD001532-fig-0043" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Probiotics versus antibiotic prophylaxis, Outcome 1 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Probiotics versus antibiotic prophylaxis, Outcome 2 E coli resistance to prophylactic drug." data-id="CD001532-fig-0044" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Probiotics versus antibiotic prophylaxis, Outcome 2 <i>E coli</i> resistance to prophylactic drug. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Probiotics versus antibiotic prophylaxis, Outcome 3 Renal parenchymal defects on DMSA scan." data-id="CD001532-fig-0045" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Probiotics versus antibiotic prophylaxis, Outcome 3 Renal parenchymal defects on DMSA scan. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Probiotics versus antibiotic prophylaxis, Outcome 4 Probiotics plus antibiotics versus antibiotics alone." data-id="CD001532-fig-0046" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Probiotics versus antibiotic prophylaxis, Outcome 4 Probiotics plus antibiotics versus antibiotics alone. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Other interventions, Outcome 1 Reimplantation surgery versus endoscopic treatment." data-id="CD001532-fig-0047" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Other interventions, Outcome 1 Reimplantation surgery versus endoscopic treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Other interventions, Outcome 2 Cranberry product versus no treatment." data-id="CD001532-fig-0048" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Other interventions, Outcome 2 Cranberry product versus no treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Other interventions, Outcome 3 Circumcision plus antibiotics versus antibiotics alone." data-id="CD001532-fig-0049" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Other interventions, Outcome 3 Circumcision plus antibiotics versus antibiotics alone. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001532-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/urn:x-wiley:14651858:media:CD001532:CD001532-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_t/tCD001532-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Other interventions, Outcome 4 Oxybutynin versus placebo." data-id="CD001532-fig-0050" src="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Other interventions, Outcome 4 Oxybutynin versus placebo.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/media/CDSR/CD001532/image_n/nCD001532-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001532-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotic prophylaxis versus surveillance or no treatment for primary vesicoureteric reflux</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Antibiotic prophylaxis versus surveillance or no treatment for primary VUR</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> primary VUR<br/> <b>Setting:</b> paediatric clinics<br/> <b>Intervention:</b> antibiotic prophylaxis<br/> <b>Comparison:</b> surveillance or no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with surveillance or no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Antibiotic prophylaxis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptomatic UTI by 1 to 2 years: antibiotics versus no prophylaxis</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>222 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>171 per 1,000<br/> (120 to 242) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.77<br/> (0.54 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1667 (9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Poor clarity of methods in many studies may lead to bias and this could explain the inconsistent findings across these studies. This reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Febrile UTI by 1 to 2 years: antibiotics versus no prophylaxis</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>143 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>118 per 1,000<br/> (80 to 172) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.83<br/> (0.56 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1667 (9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Poor clarity of methods in many studies may lead to bias and this could explain the inconsistent findings across these studies. This reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptomatic UTI; antibiotics versus placebo in trials with low risk of bias across all domains </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>173 per 1,000<br/> (81 to 364) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.85<br/> (0.40 to 1.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>943 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two relatively large studies showed consistent results but the third small study with small numbers of participants and few events was not consistent </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Resolution of VUR after 1 to 2 years: unit of analysis (children)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>153 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>223 per 1,000<br/> (108 to 456) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.46<br/> (0.71 to 2.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>262 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Poor clarity of methods in some studies and imprecision due to small numbers of included participants may lead to bias. This reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>342 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>321 per 1,000<br/> (277 to 369) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.94<br/> (0.81 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1056 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Design faults in one study reduces our confidence in the evidence</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Microbial resistance to prophylactic drug: unit of analysis (UTI)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>237 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>645 per 1,000<br/> (439 to 949) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.72<br/> (1.85 to 4.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>259 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small sample sizes of participants with UTI makes the results imprecise and reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>UTI:</b> Urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Most studies had serious design faults </p> <p><sup>2</sup> Inconsistency between study results with one study showing results opposite to the other studies </p> <p><sup>3</sup> Small number of events in most studies </p> <p><sup>4</sup> One study had a serious design fault </p> <p><sup>5</sup> Small numbers of urinary tract infections results in imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotic prophylaxis versus surveillance or no treatment for primary vesicoureteric reflux</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001532-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Surgical reimplantation of ureters plus antibiotics versus antibiotics alone for primary vesicoureteric reflux</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Surgical reimplantation of ureters plus antibiotics versus antibiotics alone for primary VUR</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> primary VUR<br/> <b>Setting:</b> paediatric clinics<br/> Intervention: surgical reimplantation of ureters plus antibiotics<br/> <b>Comparison:</b> antibiotics alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotics alone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Surgical reimplantation of ureters plus antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All symptomatic UTI by 4 to 5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>307 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>291 per 1,000<br/> (205 to 414) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.95<br/> (0.67 to 1.35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>297 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only one study evaluated this outcome so our confidence in the evidence is reduced</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Febrile UTI by 5 years: surgical correction + antibiotics versus antibiotics alone</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>220 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>95 per 1,000<br/> (59 to 154) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.43<br/> (0.27 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>429 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies evaluated this outcome but one of these had risk of bias issues so our confidence in the evidence is reduced </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat positive urine cultures by 4 to 5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>369 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>365 per 1,000<br/> (291 to 465) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.99<br/> (0.79 to 1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>479 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Three studies evaluated this outcome but two of these had risk of bias issues reducing our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New renal parenchymal defects (scars and thinning) on IVP: unit of analysis (children) at 4 to 5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>195 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>213 per 1,000<br/> (154 to 291) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.09<br/> (0.79 to 1.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>572 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Four studies evaluated this outcome but three of these had risk of bias issues reducing our confidence in the issues </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ESKD</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>38 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1,000<br/> (9 to 191) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.07<br/> (0.23 to 5.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Few participants included in the analysis and such imprecise findings are of limited clinical use </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertension</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>76 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1,000<br/> (19 to 260) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.93<br/> (0.25 to 3.42) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Few participants included in the analysis and such imprecise findings are of limited clinical use </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Correction of VUR: unit of analysis (children) after 3 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>323 per 1,000<br/> (138 to 763) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.29<br/> (0.55 to 3.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One small study at high risk of bias in all domains evaluated this outcome so our confidence in the evidence is very low </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of UTI with microbial resistance (resistant organisms)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>ESKD:</b> end‐stage kidney disease; <b>IVP:</b> intravenous pyelography; <b>RR:</b> Risk ratio; <b>UTI:</b> Urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Single study with relatively small number of included participants </p> <p><sup>2</sup> One included study was at unclear risk of attrition and selection bias </p> <p><sup>3</sup> Two studies were at unclear risk of selection bias and one had unclear allocation concealment </p> <p><sup>4</sup> Both studies had significant risk of bias issues </p> <p><sup>5</sup> Small studies with few events </p> <p><sup>6</sup> Single study at high risk of bias in all domains </p> <p><sup>7</sup> Very small study with few participants </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Surgical reimplantation of ureters plus antibiotics versus antibiotics alone for primary vesicoureteric reflux</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001532-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Endoscopic injection treatment versus antibiotics alone for primary vesicoureteric reflux</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Endoscopic injection treatment versus antibiotics alone for primary VUR</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> primary VUR<br/> <b>Setting:</b> paediatric clinics<br/> <b>Intervention:</b> endoscopic injection treatment<br/> <b>Comparison:</b> antibiotics alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotics alone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with endoscopic injection treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All symptomatic UTI by 1 to 2 years: endoscopic correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>225 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1,000<br/> (83 to 393) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.80<br/> (0.37 to 1.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies had risk of bias issues and inconsistency between results limited our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Febrile UTI by 1 to 2 years: endoscopic correction + antibiotics versus antibiotics alone </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>155 per 1,000<br/> (65 to 373) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.74<br/> (0.31 to 1.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies had risk of bias issues and inconsistency between results limited our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat positive urine culture by 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/> (0 to 0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 7.15<br/> (0.42 to 121.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single small study with no events and risk of bias issues reduces our confidence in the results </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total new and progressive Renal parenchymal abnormalities on DMSA scan at 1 to 2 years: endoscopic correction + antibiotics versus antibiotics alone (unit of analysis: children) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>102 per 1,000<br/> (31 to 336) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.20<br/> (0.36 to 3.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>208 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies had risk of bias issues and there was imprecision in the results reducing our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Resolution of VUR (grade 0) for endoscopic correction + antibiotics versus antibiotics alone (unit of analysis: children) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>156 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>418 per 1,000<br/> (244 to 720) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.69<br/> (1.57 to 4.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies had risk of bias issues and the small numbers of included participants resulted in imprecision reducing our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Microbial resistance to the prophylactic drug</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>800 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>504 per 1,000<br/> (272 to 920) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.63<br/> (0.34 to 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study reported this outcome with a small of urinary tract infections seriously limiting our confidence in this outcome </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>DMSA:</b> 99m‐techetium dimercaptosuccinic acid; <b>RR:</b> Risk ratio; <b>UTI:</b> Urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Significant risk of bias issues in all studies </p> <p><sup>2</sup> Inconsistent results between studies </p> <p><sup>3</sup> Small numbers of participants resulting in imprecision </p> <p><sup>4</sup> Small numbers of events </p> <p><sup>5</sup> Small number of events and small numbers of UTI resulting in imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Endoscopic injection treatment versus antibiotics alone for primary vesicoureteric reflux</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001532-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Macroplastique versus dextranomer/hyaluronic acid polymer (Deflux) to correct vesicoureteric reflux</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Macroplastique versus Deflux to correct VUR</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> primary VUR<br/> <b>Setting:</b> paediatric clinics<br/> <b>Intervention:</b> Macroplastique<br/> <b>Comparison:</b> Deflux </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with macroplastique</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Deflux</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of children with febrile UTI</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>74 per 1,000<br/> (30 to 180) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.09<br/> (0.45 to 2.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study with few events and risk of bias issues reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of children with afebrile UTI</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>177 per 1,000<br/> (55 to 573) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.68<br/> (0.52 to 5.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study with few events and risk of bias issues reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of ureters with persistent VUR &gt; grade 1 at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>210 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>113 per 1,000<br/> (73 to 174) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.54<br/> (0.35 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>472 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies with risk of bias issues moderately reduces our confidence in the results</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of kidneys with temporary renal dilatation after injection</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>214 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>396 per 1,000<br/> (219 to 718) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.85<br/> (1.02 to 3.35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study with few events and risk of bias issues reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ureteral obstruction</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 1,000<br/> (3 to 88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.46<br/> (0.25 to 8.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>399 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study with few events and risk of bias issues reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Post operative flank pain</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1,000<br/> (7 to 143) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.45<br/> (0.33 to 6.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study with few events and risk of bias issues reduces our confidence in the evidence </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New renal parenchymal defects on DMSA scan (kidney injury)<br/> Follow up: range 1 years to 3 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>Deflux:</b> dextranomer/hyaluronic acid polymer; <b>DMSA:</b> 99m‐techetium dimercaptosuccinic acid; <b>RR:</b> Risk ratio; <b>UTI:</b> Urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Single study with several risk of bias issues </p> <p><sup>2</sup> Small numbers of events resulting in imprecision </p> <p><sup>3</sup> Two studies with several risk of bias issues </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Macroplastique versus dextranomer/hyaluronic acid polymer (Deflux) to correct vesicoureteric reflux</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001532-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Probiotics versus antibiotic prophylaxis for primary vesicoureteric reflux</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Probiotics compared to antibiotic prophylaxis for primary VUR</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> primary VUR<br/> <b>Setting:</b> paediatric clinics<br/> <b>Intervention:</b> probiotics<br/> <b>Comparison:</b> antibiotic prophylaxis </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic prophylaxis</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with probiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All symptomatic UTI by 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>315 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>258 per 1,000<br/> (176 to 381) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.82<br/> (0.56 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>248 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both studies had significant risk of bias issues and also small numbers of included participants limiting our confidence in the results </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Febrile UTI by 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>183 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>150 per 1,000<br/> (68 to 335) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.82<br/> (0.37 to 1.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both studies had significant risk of bias issues and also small numbers of included participants limiting our confidence in the results </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>E. coli resistance to prophylactic drug</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1,000 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>380 per 1,000<br/> (210 to 690) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.38<br/> (0.21 to 0.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The single study had significant risk of bias issues and also small numbers of included participants limiting our confidence in the results </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Renal parenchymal defects on DMSA scan ‐ Patient data at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>364 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>251 per 1,000<br/> (156 to 404) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.69<br/> (0.43 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both studies had significant risk of bias issues and also small numbers of included participants limiting our confidence in the results </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Resolution of VUR</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>UTI:</b> Urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Two small studies with significant design issues </p> <p><sup>2</sup> Small numbers of included participants </p> <p><sup>3</sup> One small study with significant design issues </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Probiotics versus antibiotic prophylaxis for primary vesicoureteric reflux</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/full#CD001532-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001532-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotic prophylaxis versus placebo or no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Symptomatic UTI by 1‐2 years: antibiotics versus no prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.54, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Febrile UTI by 1‐2 years: antibiotics versus no prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.56, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Symptomatic UTI: antibiotics versus placebo in studies with low risk of bias across all domains </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>943</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.40, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Repeat positive urine cultures by 1‐3 years: continuous antibiotics versus no prophylaxis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>729</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.63, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Repeat positive urine cultures by 1‐3 years: intermittent antibiotics versus no prophylaxis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.10, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 All symptomatic UTI by 1‐2 years: allocation concealment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Adequate allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1533</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.50, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Unclear allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.38 [0.94, 58.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 All symptomatic UTI by 1‐2 years: blinding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Blinded studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>943</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.40, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Non‐blinded studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>703</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.43, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Renal parenchymal abnormality on DMSA scan: unit of analysis (children) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 New renal abnormality by 1‐3 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.33, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Deterioration of existing abnormality by 1‐2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.27, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 New and deteriorated abnormalities on DMSA scan by 1‐3 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.42, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 All abnormalities detected on DMSA scan by 1‐3 years: intermittent antibiotics versus surveillance </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.02, 8.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Resolution of VUR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Resolution of VUR after 1‐2 years: unit of analysis (children)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.71, 2.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Resolution of VUR after 2 years: unit of analysis (ureters)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.59, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1056</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.81, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Microbial resistance to prophylactic drug <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Microbial resistance to prophylactic drug: unit of analysis (UTI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.72 [1.85, 4.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 GFR at 3 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Renal growth at 3 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 All symptomatic UTI by 1‐2 years: addressing of incomplete outcome data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1646</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.53, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Adequate addressing of incomplete outcome data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1533</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.50, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Inadequate addressing of incomplete outcome data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.38 [0.94, 58.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Febrile UTI by 1‐2 years: allocation concealment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1646</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.57, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Adequate allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1533</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.54, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Unclear allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.38 [0.94, 58.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Febrile UTI by 1‐2 years: blinding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.54, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Blinded studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>943</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.47, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Non‐blinded studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>478</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.39, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Febrile UTI by 1‐2 years: addressing of incomplete outcome data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1610</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.60, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Adequate addressing of incomplete outcome data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1497</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.54, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Inadequate addressing of incomplete outcome data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.38 [0.94, 58.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Febrile UTI by 1‐2 years according to gender <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.36, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 UTI in girls</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.17, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 UTI in boys</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.53, 2.99]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotic prophylaxis versus placebo or no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001532-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Surgical reimplantation of ureters plus antibiotics versus antibiotics alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 All symptomatic UTI by 4‐5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>297</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.67, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 All symptomatic UTI between 5‐10 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.49, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 All symptomatic UTI in children followed for 10 years: surgical correction + antibiotics versus antibiotic alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.78, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Febrile UTI by 5 years: surgical correction + antibiotics versus antibiotics alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>429</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.27, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Febrile UTI between 5‐10 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.14, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Febrile UTI in children followed for 10 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.32, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Repeat positive urine cultures by 4‐5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>479</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.79, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Renal parenchymal defects (scars and thinning) on IVP: unit of analysis (children) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 New defects at 2 years: surgical correction + antibiotics versus antibiotics alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.33, 3.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 New defects (scars and thinning of parenchyma) at 4‐5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>572</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.79, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Progression of existing defects at 2 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.0 [0.45, 108.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Progression of existing defects (scars and parenchymal thinning) at 4‐5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>468</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.69, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Total new and progressive renal parenchymal defects at 2 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.00 [0.61, 133.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Total new and progressive renal parenchymal defects at 4‐5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>468</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.85, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Renal scars on IVP: unit of analysis (children) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 New scars at 4‐5 years: surgical correction + antibiotics versus antibiotics alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.84, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 New scars developing by 5‐10 years in children followed for 10 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.07, 16.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 New scars at 10 years in children followed for 10 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.53, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Repeat positive urine culture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.55, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Renal parenchymal abnormalities on DMSA scan: unit of analysis (children) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 All abnormalities detected on DMSA at 5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Deterioration of existing abnormalities between 5‐10 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Renal parenchymal defects on IVP: unit of analysis (kidneys) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 New defects at 2 years: surgical correction + antibiotics versus antibiotics alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.31, 3.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Progression of existing defects at 2 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.24, 10.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Total new and progressive defects at 2 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.24, 9.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 New defects at 4‐5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.24, 3.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 Progression of existing defects at 4‐5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.50, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 Total new and progressive defects at 4‐5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.53, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Hypertension and ESKD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 ESKD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.23, 5.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Hypertension</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.25, 3.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Hypertension at 10 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.01, 2.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 GFR measured by Schwartz formula <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 GFR at entry: surgical correction + antibiotics versus antibiotics alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 GFR at 5 years: surgical correction + antibiotics versus antibiotics alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 GFR at 10 years: surgical correction + antibiotics versus antibiotics alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Height Standard Deviation Score (SDS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Height SDS at entry for surgical correction + antibiotics versus antibiotics alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Height SDS at 10 year follow‐up for surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Correction of VUR: unit of analysis (children) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Correction of VUR after 3 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Correction of VUR: unit of analysis (ureters) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Correction of VUR after 2 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Correction of VUR at 5 years: surgical correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Surgical reimplantation of ureters plus antibiotics versus antibiotics alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001532-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Surgical reimplantation type 1 versus surgical reimplantation type 2</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Repeat positive urine culture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Persistent VUR (ureters) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Peri‐operative complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Surgical reimplantation type 1 versus surgical reimplantation type 2</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001532-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Endoscopic injection treatment versus antibiotics alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 All symptomatic UTI by 1‐2 year: endoscopic correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.37, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Febrile UTI by 1‐2 year: endoscopic correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.31, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Repeat positive urine culture by 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.15 [0.42, 121.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Febrile UTI by 1‐2 years in girls</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.55, 2.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Febrile UTI by 1‐2 years in boys</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.26 [0.46, 11.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Renal parenchymal abnormalities on DMSA scan: unit of analysis (children) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Total new and progressive abnormalities at 1‐2 years: endoscopic correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.36, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Deterioration of existing abnormalities at 2 years: endoscopic correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.09 [0.66, 6.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 New abnormalities at 2 years: endoscopic correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.5 [0.65, 203.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Renal damage on ultrasound <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 New renal parenchymal defect at 1 year for endoscopic correction + antibiotics versus antibiotics alone: unit of analysis (children) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 New renal scar at 1 year for endoscopic correction + antibiotics versus antibiotics alone: unit of analysis (kidneys) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 VUR status after treatment: unit of analysis (children) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Resolution of VUR (grade 0) for endoscopic correction + antibiotics versus antibiotics alone </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.69 [1.57, 4.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Improvement of VUR grade for endoscopic injection compared to Antibiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.01 [1.51, 2.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Microbial resistance to the prophylactic drug <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Unit of analysis (febrile UTI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Endoscopic injection treatment versus antibiotics alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001532-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Endoscopic injection treatment versus no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptomatic urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Febrile urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Renal parenchymal abnormality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Endoscopic injection treatment versus no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001532-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Different materials for endoscopic injection to correct VUR</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Macroplastique versus dextranomer/hyaluronic acid polymer (Deflux) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Febrile UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.45, 2.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Number of children with afebrile UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.68 [0.52, 5.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Number of ureters with persistent VUR &gt; grade 1 at 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.33, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Number of ureters with persistent VUR &gt; grade 1 at 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>472</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.35, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Number of kidneys with temporary renal dilatation after injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [1.02, 3.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Ureteral obstruction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.25, 8.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Post‐operative flank pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.33, 6.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 GAX 65 versus GAX 35 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Number of ureters with persistent VUR at 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Number of ureters with recurrence of VUR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dexcel versus Vantris <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Repeat positive urine culture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Refluxing ureters after treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Children with fever after treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Ureteral obstruction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Elimination, or improvement in grade, of VUR (ureters)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Different materials for endoscopic injection to correct VUR</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001532-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Probiotics versus antibiotic prophylaxis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 All symptomatic UTI by 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.56, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Febrile UTI by 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.37, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 <i>E coli</i> resistance to prophylactic drug <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.21, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Renal parenchymal defects on DMSA scan <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Patient data at 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.43, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Probiotics plus antibiotics versus antibiotics alone <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Repeat febrile UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Repeat positive urine culture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 New DMSA changes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Microbial resistance, year 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 Microbial resistance, year 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6 Microbial resistance, year 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7 Adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Probiotics versus antibiotic prophylaxis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001532-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Other interventions</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Reimplantation surgery versus endoscopic treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Repeat febrile UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 VUR resolution at 6 months (ureters)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 VUR resolution at 12 months (ureters)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 VUR resolution at 5 years (ureters)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 VUR resolution after 1 procedure (ureters)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Complications from the procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cranberry product versus no treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Repeat UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Circumcision plus antibiotics versus antibiotics alone <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Repeat symptomatic UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Repeat positive urine culture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 DMSA changes at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Oxybutynin versus placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Resolution of VUR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Improved grade of VUR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Resolved or improved grade of VUR (ureters)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Other interventions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001532.pub5/references#CD001532-tbl-0013">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001532.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD001532-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001532-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD001532-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD001532-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD001532-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD001532-note-0013">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001532\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001532\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001532\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001532\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001532\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IYhCEbRn&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001532.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001532.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001532.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001532.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001532.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715130632"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001532.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715130636"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001532.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d7f90e9191bde',t:'MTc0MDcxNTEzMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 